
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2BF4879275E4733CF4870011E9811B.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="elife">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5279943/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="eLife">
<meta name="citation_title" content="Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells">
<meta name="citation_author" content="Francesca Stillitano">
<meta name="citation_author_institution" content="Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, United States">
<meta name="citation_author" content="Jens Hansen">
<meta name="citation_author_institution" content="Department of Pharmacology and Systems Therapeutics, Systems Biology Center, Icahn School of Medicine at Mount Sinai, New York, United States">
<meta name="citation_author" content="Chi-Wing Kong">
<meta name="citation_author_institution" content="Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, United States">
<meta name="citation_author" content="Ioannis Karakikes">
<meta name="citation_author_institution" content="Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, United States">
<meta name="citation_author" content="Christian Funck-Brentano">
<meta name="citation_author_institution" content="Sorbonne Universités, UPMC Univ Paris 06, AP-HP, INSERM, CIC-1421, Institute of Cardiometabolism and Nutrition, Paris, France">
<meta name="citation_author" content="Lin Geng">
<meta name="citation_author_institution" content="Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, United States">
<meta name="citation_author" content="Stuart Scott">
<meta name="citation_author_institution" content="Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, United States">
<meta name="citation_author" content="Stephan Reynier">
<meta name="citation_author_institution" content="Cellectis Stem Cells, Paris, France">
<meta name="citation_author" content="Ma Wu">
<meta name="citation_author_institution" content="Cellectis Stem Cells, Paris, France">
<meta name="citation_author" content="Yannick Valogne">
<meta name="citation_author_institution" content="Cellectis Stem Cells, Paris, France">
<meta name="citation_author" content="Carole Desseaux">
<meta name="citation_author_institution" content="Cellectis Stem Cells, Paris, France">
<meta name="citation_author" content="Joe-Elie Salem">
<meta name="citation_author_institution" content="Sorbonne Universités, UPMC Univ Paris 06, AP-HP, INSERM, CIC-1421, Institute of Cardiometabolism and Nutrition, Paris, France">
<meta name="citation_author" content="Dorota Jeziorowska">
<meta name="citation_author_institution" content="Sorbonne Universités, UPMC Univ Paris 06, AP-HP, INSERM, CIC-1421, Institute of Cardiometabolism and Nutrition, Paris, France">
<meta name="citation_author" content="Noël Zahr">
<meta name="citation_author_institution" content="Sorbonne Universités, UPMC Univ Paris 06, AP-HP, INSERM, CIC-1421, Institute of Cardiometabolism and Nutrition, Paris, France">
<meta name="citation_author" content="Ronald Li">
<meta name="citation_author_institution" content="Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, United States">
<meta name="citation_author_institution" content="Ming Wai Lau Centre for Reparative Medicine, Karolinska Institutet, Stockholm, Sweden">
<meta name="citation_author_institution" content="Dr. Li Dak-Sum Centre, The University of Hong Kong – Karolinska Institutet Collaboration in Regenerative Medicine, Pokfulam, Hong Kong">
<meta name="citation_author" content="Ravi Iyengar">
<meta name="citation_author_institution" content="Department of Pharmacology and Systems Therapeutics, Systems Biology Center, Icahn School of Medicine at Mount Sinai, New York, United States">
<meta name="citation_author" content="Roger J Hajjar">
<meta name="citation_author_institution" content="Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, United States">
<meta name="citation_author" content="Jean-Sébastien Hulot">
<meta name="citation_author_institution" content="Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, United States">
<meta name="citation_author_institution" content="Sorbonne Universités, UPMC Univ Paris 06, AP-HP, INSERM, CIC-1421, Institute of Cardiometabolism and Nutrition, Paris, France">
<meta name="citation_publication_date" content="2017 Jan 30">
<meta name="citation_volume" content="6">
<meta name="citation_firstpage" content="e19406">
<meta name="citation_doi" content="10.7554/eLife.19406">
<meta name="citation_pmid" content="28134617">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC5279943/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC5279943/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC5279943/pdf/elife-19406.pdf">
<meta name="description" content="A large number of drugs can induce prolongation of cardiac repolarization and life-threatening cardiac arrhythmias. The prediction of this side effect is however challenging as it usually develops in some genetically predisposed individuals with ...">
<meta name="og:title" content="Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="A large number of drugs can induce prolongation of cardiac repolarization and life-threatening cardiac arrhythmias. The prediction of this side effect is however challenging as it usually develops in some genetically predisposed individuals with ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC5279943/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="5279943">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.7554/eLife.19406"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/elife-19406.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC5279943%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/5279943/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/5279943/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC5279943/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-elife.png" alt="eLife logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to eLife" title="Link to eLife" shape="default" href="https://doi.org/10.7554/eLife.19406" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">eLife</button></div>. 2017 Jan 30;6:e19406. doi: <a href="https://doi.org/10.7554/eLife.19406" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.7554/eLife.19406</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22eLife%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22eLife%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22eLife%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22eLife%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stillitano%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Francesca Stillitano</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Francesca Stillitano</span></h3>
<div class="p">
<sup>1</sup>Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, United States</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stillitano%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Francesca Stillitano</span></a>
</div>
</div>
<sup>1,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hansen%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Jens Hansen</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Jens Hansen</span></h3>
<div class="p">
<sup>2</sup>Department of Pharmacology and Systems Therapeutics, Systems Biology Center, Icahn School of Medicine at Mount Sinai, New York, United States</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hansen%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jens Hansen</span></a>
</div>
</div>
<sup>2,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kong%20CW%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Chi-Wing Kong</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Chi-Wing Kong</span></h3>
<div class="p">
<sup>1</sup>Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, United States</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kong%20CW%22%5BAuthor%5D" class="usa-link"><span class="name western">Chi-Wing Kong</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Karakikes%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Ioannis Karakikes</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Ioannis Karakikes</span></h3>
<div class="p">
<sup>1</sup>Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, United States</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Karakikes%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Ioannis Karakikes</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Funck-Brentano%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Christian Funck-Brentano</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Christian Funck-Brentano</span></h3>
<div class="p">
<sup>3</sup>Sorbonne Universités, UPMC Univ Paris 06, AP-HP, INSERM, CIC-1421, Institute of Cardiometabolism and Nutrition, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Funck-Brentano%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Christian Funck-Brentano</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Geng%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Lin Geng</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Lin Geng</span></h3>
<div class="p">
<sup>1</sup>Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, United States</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Geng%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lin Geng</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Scott%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Stuart Scott</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Stuart Scott</span></h3>
<div class="p">
<sup>4</sup>Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, United States</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Scott%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Stuart Scott</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Reynier%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Stephan Reynier</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Stephan Reynier</span></h3>
<div class="p">
<sup>5</sup>Cellectis Stem Cells, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Reynier%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Stephan Reynier</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Ma Wu</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Ma Wu</span></h3>
<div class="p">
<sup>5</sup>Cellectis Stem Cells, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Ma Wu</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Valogne%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Yannick Valogne</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Yannick Valogne</span></h3>
<div class="p">
<sup>5</sup>Cellectis Stem Cells, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Valogne%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yannick Valogne</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Desseaux%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Carole Desseaux</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Carole Desseaux</span></h3>
<div class="p">
<sup>5</sup>Cellectis Stem Cells, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Desseaux%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Carole Desseaux</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Salem%20JE%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Joe-Elie Salem</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Joe-Elie Salem</span></h3>
<div class="p">
<sup>3</sup>Sorbonne Universités, UPMC Univ Paris 06, AP-HP, INSERM, CIC-1421, Institute of Cardiometabolism and Nutrition, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Salem%20JE%22%5BAuthor%5D" class="usa-link"><span class="name western">Joe-Elie Salem</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jeziorowska%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Dorota Jeziorowska</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Dorota Jeziorowska</span></h3>
<div class="p">
<sup>3</sup>Sorbonne Universités, UPMC Univ Paris 06, AP-HP, INSERM, CIC-1421, Institute of Cardiometabolism and Nutrition, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jeziorowska%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dorota Jeziorowska</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zahr%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Noël Zahr</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Noël Zahr</span></h3>
<div class="p">
<sup>3</sup>Sorbonne Universités, UPMC Univ Paris 06, AP-HP, INSERM, CIC-1421, Institute of Cardiometabolism and Nutrition, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zahr%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Noël Zahr</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Ronald Li</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Ronald Li</span></h3>
<div class="p">
<sup>1</sup>Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, United States</div>
<div class="p">
<sup>6</sup>Ming Wai Lau Centre for Reparative Medicine, Karolinska Institutet, Stockholm, Sweden</div>
<div class="p">
<sup>7</sup>Dr. Li Dak-Sum Centre, The University of Hong Kong – Karolinska Institutet Collaboration in Regenerative Medicine, Pokfulam, Hong Kong</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Ronald Li</span></a>
</div>
</div>
<sup>1,</sup><sup>6,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Iyengar%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Ravi Iyengar</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Ravi Iyengar</span></h3>
<div class="p">
<sup>2</sup>Department of Pharmacology and Systems Therapeutics, Systems Biology Center, Icahn School of Medicine at Mount Sinai, New York, United States</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Iyengar%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Ravi Iyengar</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hajjar%20RJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Roger J Hajjar</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Roger J Hajjar</span></h3>
<div class="p">
<sup>1</sup>Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, United States</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hajjar%20RJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Roger J Hajjar</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hulot%20JS%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Jean-Sébastien Hulot</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Jean-Sébastien Hulot</span></h3>
<div class="p">
<sup>1</sup>Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, United States</div>
<div class="p">
<sup>3</sup>Sorbonne Universités, UPMC Univ Paris 06, AP-HP, INSERM, CIC-1421, Institute of Cardiometabolism and Nutrition, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hulot%20JS%22%5BAuthor%5D" class="usa-link"><span class="name western">Jean-Sébastien Hulot</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>*</sup>
</div>
<div class="cg p">Editor: <span class="name western">Janet Rossant</span><sup>8</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, United States</div>
<div id="aff2">
<sup>2</sup>Department of Pharmacology and Systems Therapeutics, Systems Biology Center, Icahn School of Medicine at Mount Sinai, New York, United States</div>
<div id="aff3">
<sup>3</sup>Sorbonne Universités, UPMC Univ Paris 06, AP-HP, INSERM, CIC-1421, Institute of Cardiometabolism and Nutrition, Paris, France</div>
<div id="aff4">
<sup>4</sup>Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, United States</div>
<div id="aff5">
<sup>5</sup>Cellectis Stem Cells, Paris, France</div>
<div id="aff6">
<sup>6</sup>Ming Wai Lau Centre for Reparative Medicine, Karolinska Institutet, Stockholm, Sweden</div>
<div id="aff7">
<sup>7</sup>Dr. Li Dak-Sum Centre, The University of Hong Kong – Karolinska Institutet Collaboration in Regenerative Medicine, Pokfulam, Hong Kong</div>
<div id="aff8">
<sup>8</sup>Hospital for Sick Children, Canada</div>
<div class="author-notes p">
<div class="fn" id="cor1">
<sup>*</sup><p class="display-inline">Email: <span>jean-sebastien.hulot@aphp.fr</span></p>
</div>
<div class="fn" id="equal-contrib">
<sup>†</sup><p class="display-inline">These authors contributed equally to this work.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2016 Jul 5; Accepted 2016 Dec 8; Collection date 2017.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2017, Stillitano et al</div>
<p>This article is distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use and redistribution provided that the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC5279943  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/28134617/" class="usa-link">28134617</a>
</div>
<div class="ra xbox p" role="complementary" aria-label="Related or updated information about this article"><div>See commentary "<a href="/articles/PMC5279939/" class="usa-link">Put to the test</a>", e24276.</div></div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>A large number of drugs can induce prolongation of cardiac repolarization and life-threatening cardiac arrhythmias. The prediction of this side effect is however challenging as it usually develops in some genetically predisposed individuals with normal cardiac repolarization at baseline. Here, we describe a platform based on a genetically diverse panel of induced pluripotent stem cells (iPSCs) that reproduces susceptibility to develop a cardiotoxic drug response. We generated iPSC-derived cardiomyocytes from patients presenting in vivo with extremely low or high changes in cardiac repolarization in response to a pharmacological challenge with sotalol. In vitro, the responses to sotalol were highly variable but strongly correlated to the inter-individual differences observed in vivo. Transcriptomic profiling identified dysregulation of genes (<em>DLG2, KCNE4, PTRF, HTR2C</em>, <em>CAMKV</em>) involved in downstream regulation of cardiac repolarization machinery as underlying high sensitivity to sotalol. Our findings offer novel insights for the development of iPSC-based screening assays for testing individual drug reactions.</p>
<p><strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.001</a></p>
<section id="kwd-group2" class="kwd-group"><p><strong>Research Organism:</strong> Human</p></section></section><section class="abstract" id="abstract2"><h2>eLife digest</h2>
<p>Common medications can disturb the electrical signals that cause the heart to beat, potentially resulting in sudden death. Many of the drugs that have these “cardiotoxic” effects were not designed to affect the heart, and include anti-allergenics and anti-vomiting drugs. In general, only a small proportion of individuals treated with these drugs will be at risk of fatal side effects; this risk variation is thought to be due to genetic differences. If these people could be reliably identified, the drugs could be used to treat others who will not develop cardiotoxic reactions, but it is difficult to predict the effect a drug will have on the beating of the heart.</p>
<p>Stillitano, Hansen et al. have now investigated whether skin cells can be used to predict an individual’s likelihood of developing cardiotoxic side effects. Skin cells can be reprogrammed to form pluripotent stem cells, which have the ability to develop into any of the cell types in the adult body – including heart muscle cells. The effects of drugs could then be tested on these artificially created heart cells, yet it is not clear whether these effects would be the same as those seen in actual heart cells</p>
<p>Stillitano, Hansen et al. created heart cells from skin samples collected from many different people and treated the cells with a drug that affects the rhythm of the heart. Some of the cells came from people whose heart rhythm is strongly affected by the drug, and others came from people whose heart rhythm is barely altered. The response of the lab-grown cells was closely related to whether the cells came from a person who was susceptible to the effects of the drug. Further investigation revealed that the genes that are important for maintaining a regular heartbeat differ in people who experience strong cardiotoxic side effects from those that do not.</p>
<p>Overall, the results presented by Stillitano, Hansen et al. support the idea that induced pluripotent stem cells could be used to predict an individual’s risk of developing cardiotoxic reactions. Further work is now needed to develop this approach.</p>
<p><strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.002</a></p></section><section id="s1"><h2 class="pmc_sec_title">Introduction</h2>
<p>A large number of drugs have the undesirable side effect of prolonging cardiac repolarization which can trigger life-threatening cardiac arrhythmias (<a href="#bib18" class="usa-link" aria-describedby="bib18">Kannankeril et al., 2010</a>). A typical cause is the inhibition of the inward rectifying potassium channel (hERG or <em>human ether-a-go-go</em> related gene encoded by <em>KCNH2</em>) (<a href="#bib18" class="usa-link" aria-describedby="bib18">Kannankeril et al., 2010</a>; <a href="#bib43" class="usa-link" aria-describedby="bib43">Roden, 2008a</a>), which results in the prolongation of the repolarization time and induces an increase of the QT interval on the electrocardiogram. The early prediction of drug-induced long QT (diLQT) is a major requirement to avoid exposing patients to cardiac arrhythmias and ultimately sudden cardiac death (<a href="#bib47" class="usa-link" aria-describedby="bib47">Sarganas et al., 2014</a>). Eventually, diLQT is a major cause of drug withdrawal or of premature termination during development (<a href="#bib11" class="usa-link" aria-describedby="bib11">Fermini and Fossa, 2003</a>). Regulatory agencies require that new drug candidates be systematically screened for hERG inhibition in animal models or in heterologous over-expression cellular systems (<a href="#bib46" class="usa-link" aria-describedby="bib46">Sager et al., 2014</a>). Because of species-dependent differences of cardiac electrophysiology and the failure of heterologous systems to express all cardiac proteins, hERG screening however remains suboptimal and has a poor positive predictive value for subsequent proarrhythmia risk (<a href="#bib13" class="usa-link" aria-describedby="bib13">Gintant, 2011</a>; <a href="#bib14" class="usa-link" aria-describedby="bib14">Giorgi et al., 2010</a>; <a href="#bib46" class="usa-link" aria-describedby="bib46">Sager et al., 2014</a>).</p>
<p>The risk of developing diLQT varies markedly between subjects. Previous studies in the general population have shown that a small proportion (i.e., less than 10%) of patients exposed to QT-prolonging drugs actually develop diLQT (<a href="#bib1" class="usa-link" aria-describedby="bib1">Behr and Roden, 2013</a>; <a href="#bib18" class="usa-link" aria-describedby="bib18">Kannankeril et al., 2010</a>; <a href="#bib51" class="usa-link" aria-describedby="bib51">Soyka et al., 1990</a>). Different observations support the existence of a genetic determinism to diLQT including the higher propensity to develop drug-induced repolarization abnormalities in first-degree relatives of patients with diLQT (<a href="#bib19" class="usa-link" aria-describedby="bib19">Kannankeril et al., 2005</a>) and the similarity to the congenital form of the long QT syndrome (LQTS), a rare inherited cardiac disorder (<a href="#bib33" class="usa-link" aria-describedby="bib33">Moss and Robinson, 1992</a>). Multiple rare mutations with marked effects in genes encoding ion channels have been reported to underlie LQTS (<a href="#bib5" class="usa-link" aria-describedby="bib5">Cerrone and Priori, 2011</a>). However, candidate gene screening studies in large cohorts of patients with diLQT have reported a small prevalence (from 10 to 15%) of these mutations in the known LQTS genes (<a href="#bib38" class="usa-link" aria-describedby="bib38">Paulussen et al., 2004</a>; <a href="#bib57" class="usa-link" aria-describedby="bib57">Yang et al., 2002</a>). QT prolongation can be induced by mutations in many genes that occupy a substantial region of the human interactome and contain many drug targets (<a href="#bib2" class="usa-link" aria-describedby="bib2">Berger et al., 2010</a>). The factors leading to diLQT in some individual subjects remain largely unclear but are probably driven by the additive effect of common genetic variants that reduce the cardiac repolarization reserve (<a href="#bib1" class="usa-link" aria-describedby="bib1">Behr and Roden, 2013</a>; <a href="#bib19" class="usa-link" aria-describedby="bib19">Kannankeril et al., 2005</a>; <a href="#bib42" class="usa-link" aria-describedby="bib42">Roden, 2006</a>, <a href="#bib44" class="usa-link" aria-describedby="bib44">2008b</a>). As a consequence, diLQT is difficult to predict as it usually develops in individuals with a predisposing genetic makeup which favors exaggerated response to a pharmacological challenge with QT-prolonging drugs (<a href="#bib18" class="usa-link" aria-describedby="bib18">Kannankeril et al., 2010</a>; <a href="#bib44" class="usa-link" aria-describedby="bib44">Roden, 2008b</a>) but does not affect cardiac repolarization features at baseline (<a href="#bib1" class="usa-link" aria-describedby="bib1">Behr and Roden, 2013</a>; <a href="#bib18" class="usa-link" aria-describedby="bib18">Kannankeril et al., 2010</a>; <a href="#bib47" class="usa-link" aria-describedby="bib47">Sarganas et al., 2014</a>).</p>
<p>Human induced pluripotent stem cells (iPSCs) have recently been proposed to model monogenic disorders including congenital LQTS (<a href="#bib17" class="usa-link" aria-describedby="bib17">Itzhaki et al., 2011</a>; <a href="#bib32" class="usa-link" aria-describedby="bib32">Moretti et al., 2010</a>; <a href="#bib49" class="usa-link" aria-describedby="bib49">Sinnecker et al., 2013</a>). Cardiomyocytes derived from congenital LQTS patient-specific iPSCs lines typically exhibit significant electrophysiological abnormalities due to the deficient function of some key cardiac ion channels (<a href="#bib17" class="usa-link" aria-describedby="bib17">Itzhaki et al., 2011</a>; <a href="#bib32" class="usa-link" aria-describedby="bib32">Moretti et al., 2010</a>). These cells display increased arrhythmogenicity under native conditions and can be used as a test system for customization of anti-arrhythmic drugs in these patients (<a href="#bib52" class="usa-link" aria-describedby="bib52">Terrenoire et al., 2013</a>; <a href="#bib56" class="usa-link" aria-describedby="bib56">Wang et al., 2014</a>). In addition, QT prolonging drugs can trigger changes in the electrical potential developed by iPSC-derived cardiomyocytes (iPSC-CMs) (<a href="#bib25" class="usa-link" aria-describedby="bib25">Liang et al., 2013</a>; <a href="#bib35" class="usa-link" aria-describedby="bib35">Navarrete et al., 2013</a>; <a href="#bib36" class="usa-link" aria-describedby="bib36">Nozaki et al., 2014</a>).</p>
<p>To expand upon these observations, our goal was to determine whether iPSC-CMs from a group of subjects with quantitative measure of diLQT in vivo could recapitulate the phenotype in vitro thereby providing a model system for diLQT. In this study, we show that iPSC-CMs from subjects shown to be susceptible to diLQT in vivo but otherwise normal present no abnormalities in their basal characteristics but higher cardiotoxic responses to drug stimulation as compared to control iPSC-CMs. The contrasted responses to sotalol in iPSC-CMs were strongly correlated to the inter-individual differences in response to sotalol as recorded during clinical investigations. Our findings offer novel insights on the use of a genetically diverse panel of induced pluripotent stem cells to model complex pharmacogenetic traits.</p></section><section id="s2"><h2 class="pmc_sec_title">Results</h2>
<section id="s2-1"><h3 class="pmc_sec_title">Identification of subjects susceptible to develop drug-induced long QT</h3>
<p>We first performed a clinical study (clinicaltrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT01338441" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01338441</a>) where we prospectively evaluated cardiac repolarization of healthy subjects in response to a pharmacological challenge with a single 80 mg oral dose of sotalol. Sotalol is a non-selective competitive β-adrenergic receptor blocker with additional Class III antiarrhythmic properties by its inhibition of potassium channels (<a href="#bib58" class="usa-link" aria-describedby="bib58">Zanetti, 1993</a>). Sotalol is widely recognized as a classical QT-prolonging drug (<a href="#bib51" class="usa-link" aria-describedby="bib51">Soyka et al., 1990</a>). A total of ninety-two subjects were enrolled in the study (<a href="#fig1" class="usa-link">Figure 1A</a>). All subjects gave their written informed consent to participate the study. Included subjects were aged from 18 to 40 years (30.1 ± 6.2 years), had a body mass index (BMI) between 19 and 29 kg/m² (23.9 ± 2.3 kg/m²), were from Caucasian origin and had no known significant disease or long-term treatment. Forty-four percent (n = 40) were male. Cardiac repolarization parameters were analyzed through standardized measurements of digital high-resolution ECG (sampling rate 1000 Hz). All subjects had a normal sinus rhythm and no significant conduction or repolarization abnormalities. Basal QT interval ranged from 340 to 458 ms (393.4 ± 26.3 ms), with a corresponding heart rate ranging from 47 to 88 bpm (63.3 ± 8.7 bpm). QT interval was corrected according to Fridericia's formula (QTcf=QT/[RR]<sup>1/3</sup>) providing corrected QTcf in the physiological range from 350 to 447 ms (399.0 ± 18.6 ms). Three hours after sotalol intake, QTcf had increased by 23.4 ± 2.4 ms. A large inter-individual variability was however noticed with a change in QTcf ranging from −9 ms to +81 ms and a resulting post-sotalol QTcf ranging from 351 to 489 ms (412.6 ± 43.0 ms) (<a href="#fig1" class="usa-link">Figure 1B</a>).</p>
<figure class="fig xbox font-sm" id="fig1"><h4 class="obj_head">Figure 1. QTcf changes following Sotalol administration in healthy volunteers.</h4>
<figcaption><p>(<strong>A</strong>) Flow chart of the clinical study. (<strong>B</strong>) Distribution of QTcf duration before (blue) and 3 hr after sotalol intake (red). (<strong>C</strong>) Distribution of delta change in QTcf showing the wide inter-individual variability in response to the same pharmacological stimulation. Subjects with the most extreme responses were selected as low sensitive (low-S) or high- sensitive (high-S) as indicated in green and red respectively. (<strong>D</strong>) Average delta change in QTcf in the two groups of selected subjects. ***p&lt;0.001. (<strong>E</strong>) Typical ECG recordings before and after sotalol intake in a high-S subject (upper panels) and in a low-S subject (lower panels). There is one figure supplement.</p>
<p><strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.003</a></p></figcaption><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5279943_elife-19406-fig1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed13/5279943/f4631e000770/elife-19406-fig1.jpg" loading="lazy" height="1213" width="748" alt="Figure 1."></a></p>
<div class="p"><figure class="fig xbox font-sm" id="fig1s1"><h5 class="obj_head">Figure 1—figure supplement 1. Overview of the clinical and experimental study and role of each partner.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5279943_elife-19406-fig1-figsupp1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed13/5279943/6ba5a6705ec7/elife-19406-fig1-figsupp1.jpg" loading="lazy" height="566" width="773" alt="Figure 1—figure supplement 1."></a></p>
<figcaption><div class="p">This translational study started with a prospective clinical study performed in a clinical investigation center near Paris, France. The objective was to identify healthy subjects with extreme responses to Sotalol 80 mg. Skin punch biopsies were performed in a total of twenty subjects, 10 with low-sensitivity and 10 with high-sensitivity to Sotalol. The fresh skin biopsies were then transferred at the Ectycell company (Romainville, France) in close vicinity of the clinical investigation center. The objective was to culture and bank human dermal fibroblasts and to derive and characterize hiPSC. iPSC clones were then anonymized before any further cardiac experiments were performed. This procedure was agreed by all partners to avoid potential biases in interpreting the recording at the cellular level. iPSCs clones were successfully generated for 17 subjects using retroviral infection and were investigated in this study. For the remaining three subjects (Patients 4, 14 and 20), iPSCs clones were secondarily generated using episomal plasmids and were thus not investigated. The 17 iPSCs clones were then transferred to the Cardiovascular Research Center at Icahn School of Medicine, New York, USA. The objective was to differentiate iPSCs into cardiac myocytes and to perform MEA recordings and drug testing. All required authorizations were obtained.</div>
<div class="p">
<strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.004</a>
</div></figcaption></figure></div>
<div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>Twenty subjects with the most extreme responses to sotalol (i.e., 10 subjects with high-sensitivity (high-S) and 10 subjects with low-sensitivity (low-S)) underwent skin biopsy (<a href="#fig1" class="usa-link">Figure 1A and C</a>). These subjects displayed highly contrasted responses to the same pharmacological stimulation (average change in QTcf: 48.5 ± 7.1 ms in high-S subjects vs. 0.2 ± 4.8 ms in low-S subjects; p&lt;0.0002; <a href="#fig1" class="usa-link">Figure 1C–E</a>) while having no significant differences in their basal ECG characteristics (<a href="#tbl1" class="usa-link">Table 1</a>). Demographic characteristics were well balanced between groups with the exception of gender, subjects with high-S being mostly female (90%, n = 9) whereas subjects with low-S were mostly males (80%, n = 8) (<a href="#tbl1" class="usa-link">Table 1</a>). Sotalol plasma level was measured 3 hr after sotalol intake and was not significantly different in subjects with high-S as compared to the other participating subjects (753.1 ± 210.9 vs. 620.7 ± 195.3 μg/ml, p=0.10).</p>
<section class="tw xbox font-sm" id="tbl1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p">
<p>Related to <a href="#fig1" class="usa-link">Figure 1</a>. Demographic, clinical and electrocardiographic baseline characteristics of subjects with low- vs. high- sensitivity to Sotalol.</p>
<p><strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.005</a></p>
</div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" rowspan="1" colspan="1"></th>
<th valign="top" rowspan="1" colspan="1">
<p><strong>Low-sensitivity, n = 10</strong></p>
</th>
<th valign="top" rowspan="1" colspan="1">
<p><strong>High- sensitivity, n = 10</strong></p>
</th>
<th valign="top" rowspan="1" colspan="1">
<p><strong>p-value</strong></p>
</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" rowspan="1" colspan="1"><p>Age</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>29.9 ± 5.9</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>28.3 ± 5.9</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.53</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p>Gender, Male (%)</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>8 (80.0%)</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>1 (10%)</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.006</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p>Body Mass Index (kg/m²)</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>23.6 ± 0.9</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>22.9 ± 2.7</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.40</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p>SBP (mmHg)</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>116.0 ± 8.6</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>113.7 ± 8.3</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.50</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p>DBP (mmHg)</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>72.2 ± 4.8</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>68.0 ± 4.2</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.07</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p>Resting heart Rate (bpm)</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>59.6 ± 5.9</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>63.2 ± 8.4</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.37</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p>PR interval (ms)</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>166.7 ± 24.7</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>143.5 ± 18.1</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.09</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p>QRS (ms)</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>88.3 ± 5.9</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>85.6 ± 7.7</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.08</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p>QTcf (ms)</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>384.7 ± 26.4</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>402.6 ± 20.8</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.13</p></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="s2-2"><h3 class="pmc_sec_title">Derivation and differentiation of iPSCs into cardiomyocytes</h3>
<p>Dermal fibroblasts were collected from the twenty subjects with high or low-sensitivity to sotalol stimulation. Human iPSCs were derived through retroviral infection of dermal fibroblasts with the reprogramming factors OCT4, SOX2, c-MYC and KLF4 with a successful generation for 17 out of the 20 subjects (<a href="#fig1s1" class="usa-link">Figure 1—figure supplement 1</a>). All iPSC clones expressed the characteristic human embryonic stem cell (ESC) pluripotency markers TRA-1–60, NANOG, OCT3/4 and SSEA-4 (<a href="#SD1-data" class="usa-link">Figure 2—source data 1</a>), had positive alkaline phosphatase staining. Sixteen iPSC clones had a normal karyotype (<a href="#tbl2" class="usa-link">Table 2</a>). One clone presented a significant translocation that was observed in originating fibroblasts. All clones showed silencing of the exogenous retroviral transgenes and reactivation of the endogenous pluripotency genes OCT3/4, NANOG and SOX2 (<a href="#fig2s1" class="usa-link">Figure 2—figure supplement 1</a>).</p>
<section class="tw xbox font-sm" id="tbl2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p">
<p>Related to <a href="#fig2" class="usa-link">Figure 2</a>. Fibroblasts and iPS quality control parameters.</p>
<p><strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.006</a></p>
</div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" rowspan="1" colspan="1">
<p><strong>ID</strong></p>
</th>
<th valign="top" rowspan="1" colspan="1">
<p><strong>Mycoplasma*</strong></p>
</th>
<th valign="top" rowspan="1" colspan="1">
<p><strong>HIV*, HBV*, HCV*, HTLV1 and 2*</strong></p>
</th>
<th valign="top" rowspan="1" colspan="1">
<p><strong>Phosphatase alkaline staining</strong></p>
</th>
<th valign="top" rowspan="1" colspan="1">
<p><strong>Karyotyping</strong></p>
</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11007" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11007</a>~5924~iPSpolyRoksmA</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1"><p>46,XY</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p>P11008~5444~iPSpolyRoksmB</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1"><p>46, XX</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11009" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11009</a>~6426~iPSpolyRoksmC</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1"><p>46, XY</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p>P11013~5744~iPSpolyRoksmD</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1"><p>46, XX</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p>P11014-5864-iPSpolyRoksmC</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1"><p>46, XX</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11015" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11015</a>~6345~iPSpolyRoksmE</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1"><p>46, XX</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11018" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11018</a>~5644~iPSpolyRoksmB</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1"><p>46, XX</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p>P11019-6444-iPSpolyRoksmB</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1"><p>46, XY</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11020" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11020</a> ~ 7125 ~ iPSpolyRoksmD</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1"><p>46, XY</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11021" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11021</a> ~ 6544 ~ iPSpolyRoksmC</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1"><p>46, XX</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11023" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11023</a>~5525~iPSpolyRoksmA</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1"><p>46, XX</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11024" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11024</a>~5844~iPSpolyRoksmA</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1"><p>46, XX</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11026" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11026</a>~6504~iPSpolyRoksmD</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1"><p>46, XY</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11028" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11028</a>~6904~iPSpolyRoksmJ</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1"><p>46, XY</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p>P11029-6284-iPSpolyRoksmB</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1"><p>46, XX</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11030" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11030</a>~5684~iPSpolyRoksmA</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>46, XX,</p>
<p>t(1;16)<sup>†</sup></p>
</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11031" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11031</a>~5204~iPSpolyRoksmC</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Negative</p></td>
<td valign="top" rowspan="1" colspan="1"><p>Positive</p></td>
<td valign="top" rowspan="1" colspan="1"><p>46, XY</p></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="tblfn1"><p>*Tested in originating fibroblast cell lines.</p></div>
<div class="fn" id="tblfn2"><p><sup>†</sup>As found in originating fibroblasts.</p></div>
</div></section><p>The generated iPSCs lines were then encoded to ensure that all further biological experiments were performed in a blinded fashion without knowledge of the associated clinical phenotype (<a href="#fig1s1" class="usa-link">Figure 1—figure supplement 1</a>). The code was kept securely by a blinded third party and was only disclosed once all characterizations and electrophysiological measurements with microelectrode array (MEA) mapping system were finalized. All classifications of lines according to the observed response to sotalol were therefore performed before the unblinding process.</p>
<p>Subject-specific iPSCs were differentiated using a small molecule-mediated directed differentiation protocol that involves sequential modulation of the canonical Wnt pathway and yields a high proportion of ventricular-like cardiomyocytes as previously described (<a href="#bib20" class="usa-link" aria-describedby="bib20">Karakikes et al., 2014</a>). As early as seven days following initiation of cardiac differentiation, spontaneously beating embryoid bodies (EBs) appeared. To test for iPSC-derived cardiomyocytes quality and purity we first performed immunocytostaining studies showing positive staining for the sarcomeric proteins troponin T (cTnT), and alpha-actinin and for the gap-junction protein connexin 43 (Cx43) (<a href="#fig2" class="usa-link">Figure 2A</a>). Cardiac troponin T staining of iPSC-CMs showed a typical striated pattern (<a href="#fig2" class="usa-link">Figure 2A</a>, upper panels). We also determined the cardiomyocytes differentiation efficiency by flow cytometry and found an average of 47.8 ± 19.9% cTNT positive cells. Importantly, after unblinding the study, we did not observe any differences between iPSC lines from the high-S vs. low-S groups (49.2 ± 24.4% vs. 46.7 ± 17.3% respectively, p=0.42). Finally, in line with previous reports (<a href="#bib25" class="usa-link" aria-describedby="bib25">Liang et al., 2013</a>), quantitative PCR demonstrated the presence of major cardiac ion channel genes found in adult left ventricular tissue, including of the relevant <em>KCNH2</em> gene (<a href="#fig2" class="usa-link">Figure 2B</a> and <a href="#SD2-data" class="usa-link">Figure 2—source data 2</a>).</p>
<figure class="fig xbox font-sm" id="fig2"><h4 class="obj_head">Figure 2. Expression of sarcomeric proteins and ion channels in human iPSC-CMs.</h4>
<figcaption><p>(<strong>A</strong>) Confocal microscopy imaging of Troponin T (top), alpha-actinin and connexin 43 (bottom) in single generated iPSC-CMs (from line <a href="https://www.ncbi.nlm.nih.gov/protein/P11015" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11015</a>). Nuclei are stained with DAPI (Blue). (<strong>B</strong>) Gene expression of cardiac ion channel <em>KCNH2</em> (encoding hERG) by quantitative PCR; Adult LV tissue is used as a positive control and the level of expression in human ESC-derived cardiomyocytes as a comparator. (<strong>C</strong>) Example of monolayer of iPSC-CMs seeded and attached on a 6-well MEA chip, each well containing nine microelectrodes (black). See also <a href="#media1" class="usa-link">Video 1</a>. (<strong>D</strong>) Representative field potential duration (FPD) recorded before and after application of the hERG blocker E4031 (from line <a href="https://www.ncbi.nlm.nih.gov/protein/P11007" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11007</a>). There are five figure supplements.</p>
<p><strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.007</a></p>
<div class="p"><section class="sm xbox font-sm" id="SD1-data"><div class="caption p">
<span>Figure 2—source data 1. iPSCs characterization.</span><div class="p">Representative immunostaining for a panel of pluripotent stem cell markers, including Nanog, OCT4, SSEA4 and TRA1-60. Results are reported for each cell line. Typical staining in hESC is reported as a positive control. Scale bar 50 μM.</div>
<div class="p">
<strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.008</a>
</div>
</div>
<div class="media p" id="d35e1365">
<div class="caption">
<a href="/articles/instance/5279943/bin/elife-19406-fig2-data1.pdf" data-ga-action="click_feat_suppl" class="usa-link">elife-19406-fig2-data1.pdf</a><sup> (44.9MB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7554/eLife.19406.008</div>
</div></section></div>
<div class="p"><section class="sm xbox font-sm" id="SD2-data"><div class="caption p">
<span>Figure 2—source data 2. Expression of main human cardiac ion channels.</span><div class="p">Quantitative PCR results for the expression of 10 major cardiac ion channels including <em>SCN5A, CACNA1, KCNQ1, KCNE1, KCNJ2, KCNJ11, KChIP2, HCN1, HCN2, HCN4. KCND3</em> was not detected. Adult LV tissue is used as a positive control and the level of expression in human embryonic stem cells-derived cardiomyocytes as a comparator.</div>
<div class="p">
<strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.009</a>
</div>
</div>
<div class="media p" id="d35e1386">
<div class="caption">
<a href="/articles/instance/5279943/bin/elife-19406-fig2-data2.pdf" data-ga-action="click_feat_suppl" class="usa-link">elife-19406-fig2-data2.pdf</a><sup> (6.5MB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7554/eLife.19406.009</div>
</div></section></div></figcaption><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5279943_elife-19406-fig2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed13/5279943/b5023d71f4b5/elife-19406-fig2.jpg" loading="lazy" height="1018" width="681" alt="Figure 2."></a></p>
<div class="p"><figure class="fig xbox font-sm" id="fig2s1"><h5 class="obj_head">Figure 2—figure supplement 1. Expression of exogenous and endogenous pluripotency genes.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5279943_elife-19406-fig2-figsupp1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed13/5279943/d101e10968a3/elife-19406-fig2-figsupp1.jpg" loading="lazy" height="719" width="743" alt="Figure 2—figure supplement 1."></a></p>
<figcaption><div class="p">Representative gel showing silencing of the four exogenous reprogramming transgenes (OCT3/4; KLF4; SOX2 ; c-MYC) and quantitative PCR results for endogenous pluripotent stem cell genes (OCT3/4; NANOG; SOX2) in the generated hiPSCs.</div>
<div class="p">
<strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.010</a>
</div></figcaption></figure></div>
<div class="p"><figure class="fig xbox font-sm" id="fig2s2"><h5 class="obj_head">Figure 2—figure supplement 2. MEA arrays.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5279943_elife-19406-fig2-figsupp2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed13/5279943/3eabc0a3a1b9/elife-19406-fig2-figsupp2.jpg" loading="lazy" height="558" width="761" alt="Figure 2—figure supplement 2."></a></p>
<figcaption><div class="p">(<strong>A</strong>) Picture of a 6-well MEA array as used in the study. Each well contains nine micro-electrodes and a limited volume capacity allowing easier contact between cells and micro-electrodes after re-seeding and rapid response to drugs after application in a limited volume of medium. (<strong>B</strong>) Typical micro-electrodes map of the six well array. (<strong>C</strong>) Dose-curve responses to the hERG blocker E4031. Increasing concentrations of E4031 were applied as described in Materials and methods section. Individual data were plotted and a hill equation was fitted allowing estimates of EC50 for each cell lines. Results were obtained in 15 cell lines as two cell lines display no changes in FPD in response to E4031, suggesting expression of a non-functional hERG in these iPSC-CMs. For graphical purposes, cell lines from the low-S group are shown in green and from the high-S group in red.</div>
<div class="p">
<strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.011</a>
</div></figcaption></figure></div>
<div class="p"><figure class="fig xbox font-sm" id="fig2s3"><h5 class="obj_head">Figure 2—figure supplement 3. Quality of FPD adjustment.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5279943_elife-19406-fig2-figsupp3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed13/5279943/ade8563da236/elife-19406-fig2-figsupp3.jpg" loading="lazy" height="365" width="716" alt="Figure 2—figure supplement 3."></a></p>
<figcaption><div class="p">(<strong>A</strong>) Plot of adjusted FPD using the Bazett’s formula against the individual inter-beat interval. This plot shows the miss-correction achieved using the Bazett’s formula with a significant dependence of FPD to beating rate even after adjustment. (<strong>B</strong>) Plot of adjusted FPD against the individual inter-beat interval after re-estimation of the correction factor to the data set. The plot shows perfect correction with linear regression indicating the lack of influence of the beating rate on the adjusted FPD.</div>
<div class="p">
<strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.012</a>
</div></figcaption></figure></div>
<div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="s2-3"><h3 class="pmc_sec_title">Genetic profiling of cell lines</h3>
<p>We then screened for common single nucleotide polymorphisms (SNPs, total of 4130) in the 15 genes associated with congenital long QT (<em>AKAP9, ANK2, CACNA1C, CALM1, CALM2, CAV3, KCNH2, KCNE1, KCNE2, KCNJ2, KCNJ5, KCNQ1, SCN4B, SCN5A, SNTA1)</em> using a high-density chip (Human Omni 2.5 genotyping array). We found 25 SNPs in <em>ANK2, SCN5A, KCNQ1, CACNA1C, CALM1, KCNE2, KCNH2</em> and <em>KCNJ5</em> as being significantly imbalanced between low-S vs. high-S groups (<a href="#tbl3" class="usa-link">Table 3</a>). This suggests the presence of an allelic series comprising multiple variants of unknown significance that can create a particular predisposing genetic background. Of note, the <em>CALM1</em> c.*1952C (rs3814843) mutated allele was recently associated with increased risk of sudden cardiac death in patients with heart failure (<a href="#bib26" class="usa-link" aria-describedby="bib26">Liu et al., 2015</a>). The allele is rare in Europeans (anticipated allelic frequency of 1.8%) but displayed a 22.2% allelic frequency in the high-S group. In addition, the rare C allele of <em>KCNH2:</em>c.307 + 1932G&gt;C polymorphism (rs3778873) was significantly more frequent in high-S as compared to low-S (minor allelic frequency: 44.4% vs. 6.2% respectively, p=0.02). <em>KCNH2</em> encodes for the hERG potassium channel that is targeted by sotalol and this variant was identified in a large genome-wide association study on the physiological regulation of QT interval (<a href="#bib40" class="usa-link" aria-describedby="bib40">Pfeufer et al., 2009</a>).</p>
<section class="tw xbox font-sm" id="tbl3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p">
<p>Related to <a href="#fig2" class="usa-link">Figure 2</a>. Single nucleotide polymorphisms in <em>ANK2, SCN5A, KCNQ1, CACNA1C, CALM1, KCNE2, KCNH2</em> and <em>KCNJ5</em> as being significantly imbalanced (p&lt;0.05) between low-S vs. high-S groups. Anticipated minor allelic frequency (MAF) was defined using the HapMap-CEU European data. The MAF in cells from the high-S vs. low-S groups was determined once the study was unblinded. Fisher’s exact test was used to compare observed MAFs in high-S vs. low-S groups.</p>
<p><strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.013</a></p>
</div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" rowspan="1" colspan="1">
<p><strong>Gene</strong></p>
</th>
<th valign="top" rowspan="1" colspan="1">
<p><strong>Rs number</strong></p>
</th>
<th valign="top" rowspan="1" colspan="1">
<p><strong>Anticipated MAF</strong></p>
</th>
<th valign="top" rowspan="1" colspan="1">
<p><strong>Observed MAF Low-S</strong></p>
</th>
<th valign="top" rowspan="1" colspan="1">
<p><strong>Observed MAF High-S</strong></p>
</th>
<th valign="top" rowspan="1" colspan="1">
<p><strong>p value</strong></p>
</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" rowspan="1" colspan="1">
<p>ANK2</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>rs17045935</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>6.8%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>0%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>22.2%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.03</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p>rs62314901</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>40%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>56.25%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>27.8%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.037</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p>rs17676256</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>10.2%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>12.5%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>38.9%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.03</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p>rs967099</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>38.1%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>25%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>44.4%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.027</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p>rs4834321</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>46.9%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>37.5%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>55.6%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.02</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p>rs35308370</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>48.3%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>25%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>66.7%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.025</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p>rs931838</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>42.5%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>31.25%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>66.7%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.048</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">
<p>SCN5A</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>rs7375123</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>19.2%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>43.75%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>11.2%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.007</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p>rs12491987</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>7.6%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>0%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>22.2%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.03</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p>rs9871385</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>34.1%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>6.25%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>33.3%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.02</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p>rs9818148</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>19.2%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>56.25%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>16.7%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.049</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">
<p>KCNQ1</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>rs4255520</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>15.5%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>18.75%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>0%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.043</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p>rs151288</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>32.7%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>0%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>22.2%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.031</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1">
<p>rs718579</p>
<p>rs11022996</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>39.8%</p>
<p>41.2%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>12.5%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>27.8%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.034</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p>rs151212</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>40.8%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>50%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>33.3%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.05</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">
<p>CACNA1C</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>rs3794299</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>12.4%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>18.75%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>0%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.043</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1">
<p>rs4765661</p>
<p>rs2238018</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>15.8%</p>
<p>17.3%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>31.25%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>5.6%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.027</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">
<p>CALM1</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>rs3814843</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>1.8%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>0%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>22.2%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.031</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p>rs2300502</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>7.5%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>6.25%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>33.3%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.023</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">
<p>KCNE2</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>rs28409368</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>30.8%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>18.75%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>38.9%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.0239</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">
<p>KCNH2</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>rs2072411</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>37.5%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>18.75%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>44.4%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.027</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p>rs3778873</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>15.8%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>6.2%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>44.4%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.02</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">
<p>KCNJ5</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>rs7924416</p></td>
<td valign="top" rowspan="1" colspan="1">
<p>24.6%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>0%</p>
</td>
<td valign="top" rowspan="1" colspan="1">
<p>27.8%</p>
</td>
<td valign="top" rowspan="1" colspan="1"><p>0.013</p></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="s2-4"><h3 class="pmc_sec_title">The library of iPSC-CMs reproduces susceptibility to develop cardiotoxic drug response</h3>
<p>To evaluate the electrophysiological properties of iPSC-CMs, we used a microelectrode array (MEA) mapping system (<a href="#fig2s2" class="usa-link">Figure 2—figure supplement 2</a>). iPSC-CMs were seeded onto a 6-well MEA chamber in order to form a monolayer in contact with the electrodes. Few days after seeding iPSC-CMs regain spontaneous beating activity thus allowing recordings of field potential duration (FPD) (<a href="#fig2" class="usa-link">Figure 2C–D</a> and <a href="#media1" class="usa-link">Video 1</a>). FPD is analogous to the QT interval in the electrocardiogram (ECG) and was previously shown to correlate with action potential duration (APD) and can be used to test drug effects on repolarization (<a href="#bib35" class="usa-link" aria-describedby="bib35">Navarrete et al., 2013</a>). IPSC-CMs were first tested for their responses to E4031, a specific and potent experimental hERG blocker. E4031 resulted in a dose-dependent increase in FPD with typical flattening of the waveform in all but two cell lines (<a href="#fig2" class="usa-link">Figure 2D</a> and <a href="#fig2s2" class="usa-link">Figure 2—figure supplements 2</a> and <a href="#fig2s3" class="usa-link">3</a>). There was moderate inter-line variability, except for line <a href="https://www.ncbi.nlm.nih.gov/protein/P11019" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11019</a> which demonstrated higher sensitivity to E-4031 and was found to belong to the high-S group after unblinding. There was however no significant differences in sensitivity to E4031 between groups as assessed by computations of half maximal effective concentration EC50 (2.4 ± 0.7 × 10<sup>−8</sup> vs 6.6 ± 3.0 × 10<sup>−8</sup> M in high-S and low-S groups respectively, p=0.59) or of maximal effect Emax (49 ± 20% vs 30 ± 2% in high-S and low-S groups respectively, p=0.76). Two lines displayed no responses to E4031 and were found as having the lowest expression of hERG (<a href="https://www.ncbi.nlm.nih.gov/protein/P11021" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11021</a> and <a href="https://www.ncbi.nlm.nih.gov/protein/P11023" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11023</a>, <a href="#fig2" class="usa-link">Figure 2B</a>). Because of the lack of response to a pure hERG blocker and of appropriate recordings to detect effects of QT prolonging drugs with the MEA system, sotalol response was not further tested on these two lines.</p>
<figure class="fig xbox font-sm" id="media1"><h4 class="obj_head">Video 1. Spontaneous beating activity of monolayer iPSC-CMs seeded onto one well of a 6-well MEA chamber.</h4>
<div class="media-box p text-center margin-x-neg-2 tablet:margin-x-0"><video controls="" preload="none" height="360" width="480" poster="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/video_poster.png"><source src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed13/5279943/936d4639cd39/elife-19406-media1-pmcvs_normal.mp4"></source><div class="media-fallback margin-x-2 tablet:margin-x-0">
<div>Your browser is not supporting the HTML5 &lt;video&gt; element.</div>
<div>You may download that video as a file and play it with a player of you choice.</div>
<p><a href="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed13/5279943/936d4639cd39/elife-19406-media1-pmcvs_normal.mp4" class="usa-link">Download video stream</a>.</p>
</div></video></div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/5279943/bin/elife-19406-media1.mp4" data-ga-action="click_feat_suppl" class="usa-link">Download video file</a><sup> (13.4MB, mp4) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7554/eLife.19406.014</div>
</div>
<div class="p text-right font-secondary"><a href="figure/media1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.014</a></p></figcaption></figure><p>The response to the clinically relevant drug sotalol was then tested in a blinded fashion in the remaining lines. For quality purposes, results from the iPSC line presenting a significant translocation were excluded from further analyses. However, the inclusion of the results obtained with this iPSC line did not change the statistical significance of the results. Final analyses were thus performed on a total of 14 lines (7 vs. 7 lines in low-S and high-S groups respectively).</p>
<p>After unblinding, we found that the different recordings showed a significantly higher response to sotalol in the CMs generated from iPSCs derived from high-S subjects as compared to low-S subjects (<a href="#fig3" class="usa-link">Figure 3A–D</a>). Increasing sotalol concentrations was associated with a significant prolongation in FPDs in all iPSC-CMs, an effect that was however significantly enhanced in lines from the high-S group (<a href="#fig3" class="usa-link">Figure 3A</a>). There was a dose-dependent sotalol-induced FPD prolongation that typically appears for sotalol concentrations above 30 μmol/L (<a href="#fig3" class="usa-link">Figure 3A</a>), as seen in other reports (<a href="#bib35" class="usa-link" aria-describedby="bib35">Navarrete et al., 2013</a>). Of note, the application of low sotalol concentration (10 μmol/L), a concentration this is closer to typical sotalol plasma levels, was already associated with a significant increase in FPD in lines from the high-S group as compared to low-S (p=0.03). The maximal FPD prolongation observed in response to sotalol was also significantly higher in the high-S as compared to low-S iPSC-CMs (52 ± 6% vs. 27 ± 6%, p=0.02, <a href="#fig3" class="usa-link">Figure 3B</a>). Sotalol is known to induce arrhythmic events including ectopic beats and short-long-short rhythm. We found that 5 of the seven lines derived from the high-S group displayed arrhythmias in response to sotalol stimulation as they showed development of irregular spontaneous beating rate. On the other hand, arrhythmias only occurred in one of the eight lines from the low-S group (<a href="#fig3" class="usa-link">Figure 3C</a>). We plotted the relative change in FPD in response to sotalol 30 μM against the observed change in QTcf in donors (<a href="#fig3" class="usa-link">Figure 3D</a>). With the exception of one cell line in each group, the remaining six low-S and six high-S cell lines were correctly discriminated according to the clinical phenotype. These data indicate that the contrasted responses to sotalol in iPSC-derived CMs are strongly related to the inter-individual differences in response to sotalol as recorded during clinical investigations.</p>
<figure class="fig xbox font-sm" id="fig3"><h4 class="obj_head">Figure 3. Differences in iPSC-CMs responses to Sotalol stimulation according to clinical sensitivity to Sotalol.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5279943_elife-19406-fig3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed13/5279943/faf84443697b/elife-19406-fig3.jpg" loading="lazy" height="1180" width="650" alt="Figure 3."></a></p>
<div class="p text-right font-secondary"><a href="figure/fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) Adjusted FPD (aFPD) measured in iPSC-CMs derived from subjects with low-sensitivity (green) vs. high-sensitivity (red) in response to increasing concentrations of sotalol. aFPD are normalized to baseline values to account for inter-lines variability in aFPD values. Two-way analysis of variance demonstrates a significant influence of sotalol concentrations (p&lt;0.0005) and of the sensitivity group (p&lt;0.02). *p&lt;0.05 for post-hoc comparison between groups; high-S vs. low-S. N = 2–5 recordings per cell lines per concentrations. (<strong>B</strong>) Maximal change in aFPD observed during sotalol stimulation. (<strong>C</strong>) Proportion of observed arrhythmias after sotalol application. (<strong>D</strong>) Data plot graph showing the correlation between aFPD observed in iPSC-CMs and the DeltaQTcf observed in donors. The aFPD data are reported for sotalol 30 μM concentration. Data points are clustered in two distinct groups. Except for two lines (one line in each group), a threshold a 25% in aFPD change (dashed line) correctly discriminates cells from both groups.</p>
<p><strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.015</a></p></figcaption></figure><p>We also evaluated the effect of sotalol on action potential duration (APD) measured in a representative iPSC-CMs line from each group (<a href="https://www.ncbi.nlm.nih.gov/protein/P11009" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11009</a> as low-S and <a href="https://www.ncbi.nlm.nih.gov/protein/P11029" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11029</a> as high-S). Experimenter for APD measurement was however kept blinded of the observed drug sensitivity of selected iPS lines. Sotalol (100 and 300 µM) significantly prolonged the action potential, the duration of 90% repolarization (APD<sub>90</sub>) of high-S (<a href="https://www.ncbi.nlm.nih.gov/protein/P11029" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11029</a>) iPSC-CMs (289 ± 22 in drug-free vs. 492 ± 66 and 435 ± 92 after 100 and 300 µM sotalol, respectively n = 5) but not that of the low-S line (<a href="https://www.ncbi.nlm.nih.gov/protein/P11009" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11009</a>) even at high dose (339 ± 63 vs. 450 ± 77 ms after 300 µM sotalol, n = 5) (<a href="#fig4" class="usa-link">Figure 4A–B</a> and <a href="#tbl4" class="usa-link">Table 4</a>).</p>
<figure class="fig xbox font-sm" id="fig4"><h4 class="obj_head">Figure 4. Patch-clamp analysis of action potential (AP) in representative iPSC-CMs.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5279943_elife-19406-fig4.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed13/5279943/9f29853f7371/elife-19406-fig4.jpg" loading="lazy" height="1062" width="696" alt="Figure 4."></a></p>
<div class="p text-right font-secondary"><a href="figure/fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) Representative AP tracings of the iPSC-CMs generated from the low-S (<a href="https://www.ncbi.nlm.nih.gov/protein/P11009" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11009</a>) and high-S (<a href="https://www.ncbi.nlm.nih.gov/protein/P11029" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11029</a>) lines in control and sotalol-treated conditions. (<strong>B</strong>) bar chart summarizing the APD<sub>90</sub> in control and sotalol-treated conditions for the hiPSC-CMs generated from both low-S (<a href="https://www.ncbi.nlm.nih.gov/protein/P11009" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11009</a>) and high-S (<a href="https://www.ncbi.nlm.nih.gov/protein/P11029" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11029</a>) hiPSC cell lines (n = 5 for each condition). *p&lt;0.05; **p&lt;0.01, ANOVA, followed by Tukey's, sotalol-treated versus respective control without sotalol application.</p>
<p><strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.016</a></p></figcaption></figure><section class="tw xbox font-sm" id="tbl4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p">
<p>Related to <a href="#fig4" class="usa-link">Figure 4</a>. AP parameters of low-S and high-S iPSC-derived cardiomyocytes at baseline control condition. AP data are mean ± SE. APD50/APD90, AP duration measured at 50% or 90% repolarization; MDP, maximum diastolic potential. None of the baseline AP parameters was significantly different between the two cell lines.</p>
<p><strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.017</a></p>
</div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" rowspan="1" colspan="1"></th>
<th valign="top" rowspan="1" colspan="1"><p>Low-S (11009) (n=7)</p></th>
<th valign="top" rowspan="1" colspan="1"><p>High-S (11029) (n=5)</p></th>
</tr></thead>
<tbody>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p>Firing Frequency (mV)</p></td>
<td rowspan="1" colspan="1">
<p>1.26 ± 0.29</p>
</td>
<td rowspan="1" colspan="1">
<p>1.03 ± 0.28</p>
</td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p>Amplitude (mV)</p></td>
<td rowspan="1" colspan="1">
<p>88.3 ± 3.6</p>
</td>
<td rowspan="1" colspan="1">
<p>85.1 ± 4.7</p>
</td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p>Upstroke velocity (mV/ms)</p></td>
<td rowspan="1" colspan="1">
<p>11.7 ± 1.0</p>
</td>
<td rowspan="1" colspan="1">
<p>14.0 ± 2.0</p>
</td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p>Decay velocity (mV/ms)</p></td>
<td rowspan="1" colspan="1">
<p>−7.2 ± 1.4</p>
</td>
<td rowspan="1" colspan="1">
<p>−11.1 ± 3.5</p>
</td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p>APD50 (ms)</p></td>
<td rowspan="1" colspan="1">
<p>306.4 ± 57.9</p>
</td>
<td rowspan="1" colspan="1">
<p>299.4 ± 22.0</p>
</td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p>APD90 (ms)</p></td>
<td rowspan="1" colspan="1">
<p>341.8 ± 58.6</p>
</td>
<td rowspan="1" colspan="1">
<p>338.4 ± 21.4</p>
</td>
</tr>
<tr>
<td valign="bottom" rowspan="1" colspan="1"><p>MDP (mV)</p></td>
<td rowspan="1" colspan="1">
<p>−69.4 ± 3.2</p>
</td>
<td rowspan="1" colspan="1">
<p>−68.0 ± 1.3</p>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="s2-5"><h3 class="pmc_sec_title">Dysregulation of downstream regulators of cardiac ion channels</h3>
<p>To gain insight into molecular mechanisms leading to differential susceptibility to developing diLQT, we performed a transcriptomic profiling of iPSC-CMs from high-S vs. low-S groups using RNA-sequencing. We looked for differentially expressed genes (DEGs) between the two groups (all cell lines included) and used a prior knowledge based approach to identify potential risk markers that could be mechanistically connected to QT prolongation development. By analyzing the LQTS neighborhood in the human interactome we recently demonstrated that graph theoretical models allow the prediction of new gene variants and drug targets that are involved in disease pathogenesis (<a href="#bib2" class="usa-link" aria-describedby="bib2">Berger et al., 2010</a>). Here, we used a similar approach and searched for differentially expressed direct neighbors of the known congenital LQTS genes in the human interactome (<a href="#fig5" class="usa-link">Figure 5A</a>). Of note, expression of these LQTS genes was similar between high-S and low-S groups. We identified four up-regulated (<em>DLG2, KCNE4, PTRF,</em> and <em>HTR2C</em>) and one down-regulated direct neighbors (<em>CAMKV</em>) (<a href="#fig5" class="usa-link">Figure 5A–B</a>). Among these newly identified candidates, <em>DLG2</em> (a member of the family of anchoring proteins called MAGUK), <em>KCNE4</em> (a regulatory sub-unit of potassium channel), <em>CAMKV</em> (a kinase-like protein that, in the presence of calcium, interacts with calmodulin (<em>CALM1</em>), and <em>PTRF</em> (Polymerase I and transcript release factor, or cavin-1) were relevant candidates as downstream regulators of cardiac ion channels.</p>
<figure class="fig xbox font-sm" id="fig5"><h4 class="obj_head">Figure 5. Identification of dysregulated genes as direct neighbors of QT-associated network in high-S iPSC-CMs.</h4>
<figcaption><p>(<strong>A</strong>) Known LQTS genes were used as seed nodes (green squares) in the human interactome and five differentially expressed direct neighbors were identified (circles) (path length 1). Up-regulated genes are colored orange, down-regulated genes are in blue. (<strong>B</strong>) Relative expression of identified genes in each group. Males are represented in blue and females in red. Individual samples are represented by the same symbols in all diagrams. (<strong>C</strong>) Comparison of the log2-fold changes between the high-S and the low-S groups with the normalized counts of how often a gene (blue or orange dots) was found to be up- or down-regulated between the male and female groups. As there are more females in the high-S group and more males in the low-S groups, report of genes in the lower left or upper right quadrants indicate a gender-specific effect while the lower right and upper left quadrants argue for the lack of gender-specific effect. Except for <em>HTR2C</em>, dysregulation of all other candidate genes was suspected to occur independently of gender. There is one figure supplement.</p>
<p><strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.018</a></p></figcaption><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5279943_elife-19406-fig5.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed13/5279943/0a159c73d619/elife-19406-fig5.jpg" loading="lazy" height="707" width="782" alt="Figure 5."></a></p>
<div class="p"><figure class="fig xbox font-sm" id="fig5s1"><h5 class="obj_head">Figure 5—figure supplement 1. Prediction of sex hormones-related transcription factors.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5279943_elife-19406-fig5-figsupp1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed13/5279943/048a3dd3c23d/elife-19406-fig5-figsupp1.jpg" loading="lazy" height="1052" width="636" alt="Figure 5—figure supplement 1."></a></p>
<figcaption><div class="p">Predicted regulatory transcription factors of the identified DEGs (<em>DLG2, KCNE4, CAMKV, PTRF, HTR2C)</em> based on two transcription factor target databases (Chea background and Transfac) and ranked by significance. The sex-hormone related transcription factors (in orange) were ranked 16 (AR), 20 (ESR1) and 24 (ESR2) or 27 (PGR) and 180 (ESR1) while the top 10 candidates were independent of sex hormones influence (in blue).</div>
<div class="p">
<strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.019</a>
</div></figcaption></figure></div>
<div class="p text-right font-secondary"><a href="figure/fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>The expression levels of the genes between the low-S and the high-S groups show that the risk specific expression (i.e. low expression for <em>CAMKV</em> and high expression for the other direct neighbors) does not accumulate on a few high-S subjects but is more or less equally distributed over all high-S subjects (<a href="#fig5" class="usa-link">Figure 5B</a>). Each subject has a risk-associated expression of at least one direct neighbor, arguing for multiple ways to disturb the LQTS genes and therefore confer different susceptibility to develop diLQT.</p>
<p>Since most of the high-sensitivity subjects were females, while most of the low sensitivity subjects were males, we then estimated whether gender could impact our results. To neutralize gender-specific effects on gene expression, we generated new groups consisting of one high-S and one low-S subject of the same gender (16 female groups, six male groups, <a href="#tbl5" class="usa-link">Table 5</a>). DEGs were identified between all possible combinations of one female versus one male group (16 × 6 = 96 sets of DEGs). We counted for each gene how many sets of DEGs identified the gene as significantly up-regulated or down-regulated. Down-regulated counts were subtracted from up-regulated counts and resulting netto counts were normalized to the number of total comparisons (i.e. divided by 96). Using this approach, a gene that is up-regulated in the high-S group because of gender specific expression, should be identified as significantly up-regulated in most of the female versus male groups sets of DEGs. The same accounts for down-regulated genes. As shown in <a href="#fig5" class="usa-link">Figure 5B and C</a>, this trend was not observed for most of the genes, arguing against gender differences being the reason for differential gene expression between the high-S and low-S group.</p>
<section class="tw xbox font-sm" id="tbl5"><h4 class="obj_head">Table 5.</h4>
<div class="caption p">
<p>Related to <a href="#fig5" class="usa-link">Figure 5</a>. Generation of new groups associating one high-S and one low-S line of the same gender (six groups for males and 16 groups for females) in order to neutralize gender-specific effects on gene expression. These groups were then used to determine DEGs between the high-S and low-S groups independent of gender.</p>
<p><strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.020</a></p>
</div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" rowspan="1" colspan="1">
<p><strong>Male groups</strong></p>
</th>
<th valign="top" rowspan="1" colspan="1">
<p><strong>Female groups</strong></p>
</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11019" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11019</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11028" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11028</a> (low)</p></td>
<td valign="top" rowspan="1" colspan="1"><p>P11008 (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11030" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11030</a> (low)</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11019" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11019</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11026" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11026</a> (low)</p></td>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11015" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11015</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11030" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11030</a> (low)</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11019" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11019</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11020" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11020</a> (low)</p></td>
<td valign="top" rowspan="1" colspan="1"><p>P11013 (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11030" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11030</a> (low)</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11019" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11019</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11009" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11009</a> (low)</p></td>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11029" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11029</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11030" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11030</a> (low)</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11019" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11019</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11031" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11031</a> (low)</p></td>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11018" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11018</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11030" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11030</a> (low)</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11019" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11019</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11007" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11007</a> (low)</p></td>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11024" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11024</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11030" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11030</a> (low)</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11023" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11023</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11030" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11030</a> (low)</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11021" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11021</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11030" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11030</a> (low)</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p>P11008 (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11014" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11014</a> (low)</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11015" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11015</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11014" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11014</a> (low)</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p>P11013 (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11014" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11014</a> (low)</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11029" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11029</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11014" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11014</a> (low)</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11018" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11018</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11014" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11014</a> (low)</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11024" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11024</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11014" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11014</a> (low)</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11023" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11023</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11014" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11014</a> (low)</p></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"></td>
<td valign="top" rowspan="1" colspan="1"><p><a href="https://www.ncbi.nlm.nih.gov/protein/P11021" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11021</a> (high) + <a href="https://www.ncbi.nlm.nih.gov/protein/P11014" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11014</a> (low)</p></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Finally, to further investigate if the DEGs are the consequence of sex specific gene expression, we predicted regulatory transcription factors of the DEGs based on two transcription factor target databases and ranked them by significance (<a href="#fig5s1" class="usa-link">Figure 5—figure supplement 1</a>). The sex-hormone related transcription factors were ranked 16 (AR), 20 (ESR1) and 24 (ESR2) or 27 (PGR) and 180 (ESR1), and no sex hormone related transcription factor was among the top 10 candidates. These data suggest that the observed differences in expression patterns between high-S and low-S iPS-CMs are mostly indicative of a signature associated with drug sensitivity rather than a gender effect.</p></section></section><section id="s3"><h2 class="pmc_sec_title">Discussion</h2>
<p>Our data illustrate the potential of using a genetically diverse panel of subject-specific iPSCs to model complex and acquired phenotypes. So far, iPSCs technology has been successful in recapitulating monogenic diseases with clear causative mutations including congenital long QT syndrome (<a href="#bib17" class="usa-link" aria-describedby="bib17">Itzhaki et al., 2011</a>; <a href="#bib32" class="usa-link" aria-describedby="bib32">Moretti et al., 2010</a>; <a href="#bib50" class="usa-link" aria-describedby="bib50">Sinnecker et al., 2014</a>). In contrast, diLQT develop in clinically normal individuals who have a genetic predisposition requiring an additional stressor to become manifest (<a href="#bib42" class="usa-link" aria-describedby="bib42">Roden, 2006</a>, <a href="#bib44" class="usa-link" aria-describedby="bib44">2008b</a>). The exact nature of this predisposing genetic background remains uncertain (<a href="#bib39" class="usa-link" aria-describedby="bib39">Petropoulou et al., 2014</a>) but is likely made of an allelic series of common variants with modest independent effect on cardiac repolarization but potential for a stronger impact in a polygenic model, as exemplified by our genetic profiling.</p>
<p>Here, we provide evidence that susceptibility to develop diLQT can be best reproduced in vitro using a targeted library of iPSCs derived from patients presenting with an extreme pharmacodynamic response to drug stimulation in vivo. Extreme phenotype selection is a well-defined methodology that helps enrich the frequency of alleles that contribute to a trait and this methodology has been successfully applied in genetic studies aimed at identifying variants associated with complex traits (<a href="#bib8" class="usa-link" aria-describedby="bib8">Cirulli and Goldstein, 2010</a>). The use of this methodology is particularly suitable when investigating variability in drug responses by segregating individuals with opposite predisposing genetic makeup, a characteristic that can be transmitted to iPSCs as shown by our data. Importantly, in order to avoid experimental biases, in vitro assessment of iPSC-CMs sensitivity to sotalol was performed blinded to the clinical phenotype. In addition, as we aimed at reproducing a more complex phenotype, we designed our study with a larger sample size than typical studies using iPSCs for disease modeling of monogenic disorders. As a consequence, we were only able to explore one iPSC clone per patient and we did not evaluate potential inter-line variability. The likelihood that inter-line variability would have systematically biased our results to reproduce the anticipated effect as seen in vivo and thus explain our results is however unlikely on a panel of 17 different cell lines as appreciated by low p-values for comparison between groups (<a href="#fig3" class="usa-link">Figures 3</a> and <a href="#fig4" class="usa-link">4</a>). Under our hypothesis, it is likely that the discrepant results obtained in two cell lines reflect that potential false results associated with inter-line variability from a same patient. However, external replication would further strengthen the potential of subject-specific iPSCs to model complex phenotypes as shown in our seminal study.</p>
<p>This library also represents a unique opportunity to explore the molecular mechanisms underlying pro-arrhythmic adverse drug reactions. The transcriptomic comparison of the generated iPSC-CMs from both groups combined with bioinformatics network analysis revealed significant changes in expression of genes related to the regulation of ion channels homeostasis (<em>DLG2, KCNE4, CAMKV</em> and <em>PTRF</em>). Of note, while none of these genes have been previously associated with the occurrence of diLQT, <em>CAMKV</em> is coding for a kinase-like protein that, in the presence of calcium, interacts with calmodulin (<em>CALM1</em>), a critical regulator of ion channels involved in congenital long QT syndrome 14 (<a href="#bib9" class="usa-link" aria-describedby="bib9">Crotti et al., 2013</a>) and in loperamide-induced long QT (<a href="#bib2" class="usa-link" aria-describedby="bib2">Berger et al., 2010</a>). Additionally, mutations in <em>PTRF</em> (Polymerase I and transcript release factor, or cavin-1) cause a particular form of congenital generalized lipodystrophy (type 4, CGL4) that is associated with features of long QT syndrome and high rate of sudden cardiac death (<a href="#bib41" class="usa-link" aria-describedby="bib41">Rajab et al., 2010</a>). <em>PTRF</em> is involved in the formation of caveolae (<a href="#bib34" class="usa-link" aria-describedby="bib34">Nabi, 2009</a>), that are critical in cardiac ion channels trafficking to the plasma membrane (<a href="#bib28" class="usa-link" aria-describedby="bib28">Maguy et al., 2006</a>). In addition to the involvement of <em>DLG2</em> and <em>KCNE4</em> genes in the direct regulation of scaffolding, trafficking and gating kinetics of some cardiac potassium channels (<a href="#bib23" class="usa-link" aria-describedby="bib23">Leonoudakis et al., 2004</a>; <a href="#bib24" class="usa-link" aria-describedby="bib24">Levy et al., 2010</a>), our study suggest for the first time that diLQT might be related to changes in downstream regulation of the cardiac repolarization machinery. Further experiments will be required to understand the exact contribution of each of these candidates and whether they might act in combination to confer susceptibility to develop diLQT. Similarly, future studies using single-cell RNA sequencing on cardiomyocytes derived from our library of subject-specific iPSCs would be needed to better identify and characterize differentially expressed genes and pathways. Lastly, we identified an up-regulation in <em>HTR2C</em> (5-hydroxytryptamine receptor 2C), a G-protein coupled receptor for serotonin that is expressed in the heart. Upon activation HTR2C activates down-stream signaling cascades to promote the release of Ca2+ from internal stores. Interestingly, serotonin receptor agonists have been associated with higher risk for diLQT (<a href="#bib21" class="usa-link" aria-describedby="bib21">Keller and Di Girolamo, 2010</a>; <a href="#bib47" class="usa-link" aria-describedby="bib47">Sarganas et al., 2014</a>). Intriguingly, we found non-significant trends for differences between groups in response to E-4031, a selective hERG channel blocker. Sotalol primarily prolongs cardiac repolarization through hERG inhibition but also have a non-selective competitive β-adrenergic receptor blocker activity and can thus affect other cardiac repolarization components that are associated with higher susceptibility to develop diLQT. Whether sotalol has a direct or indirect effect on the candidates identified in this study would deserve further investigations.</p>
<p>Many studies have reported a higher susceptibility to diLQT in premenopausal women as compared to men including in response to sotalol (<a href="#bib10" class="usa-link" aria-describedby="bib10">Darpo et al., 2014</a>; <a href="#bib29" class="usa-link" aria-describedby="bib29">Makkar et al., 1993</a>), an observation that is in line with the results of our prospective clinical investigation. It has been suggested that sex hormones can influence cardiac repolarization by modulating expression and function of cardiac ion channels but their effect is complex to appreciate as levels fluctuate with time and age and the different sex hormones can have counterbalancing effects (<a href="#bib15" class="usa-link" aria-describedby="bib15">Hulot et al., 2003</a>; <a href="#bib37" class="usa-link" aria-describedby="bib37">Odening and Koren, 2014</a>). Here, we were able to reproduce susceptibility to develop diLQT in vitro in a hormone-free environment. We performed specific analyses that did not support an important role of gender to explain our results, including the lack of a gender-specific gene expression signature and the lack of significant sex hormone-related transcription factors. Importantly, our data suggest that the identified genes should work as predisposing genes in both genders thus arguing for the existence of an intrinsic predisposing background that is carried by iPS cells but do not depend on gender. Of note, it has recently been shown that women have in mean a greater intrinsic sensitivity to sotalol as compared to men, an effect that however remains widely variable at the individual level (<a href="#bib10" class="usa-link" aria-describedby="bib10">Darpo et al., 2014</a>).</p>
<p>The development of a new generation of human-based screening assays for testing individual drug reactions (<a href="#bib16" class="usa-link" aria-describedby="bib16">Inoue and Yamanaka, 2011</a>; <a href="#bib30" class="usa-link" aria-describedby="bib30">Mann, 2015</a>) could help in better predicting adverse drug effect that usually develop in a relatively low proportion of susceptible individuals in the general patient population (<a href="#bib3" class="usa-link" aria-describedby="bib3">Budnitz et al., 2006</a>). Interestingly, we were able to detect significant differences in response to the lowest sotalol concentrations (i.e., 10 µM) in iPSC-derived cardiomyocytes from subjects clinically presenting with high sensitivity to sotalol. This suggests that the iPSC-derived platform could efficiently detect individual differences in the range of concentrations that is near the typical sotalol plasma levels. Finally, further developments in differentiation protocols (<a href="#bib4" class="usa-link" aria-describedby="bib4">Burridge et al., 2014</a>), in functional maturation of iPSC-derived cells (<a href="#bib27" class="usa-link" aria-describedby="bib27">Lundy et al., 2013</a>) or in iPSC-based bioengineering (<a href="#bib48" class="usa-link" aria-describedby="bib48">Schaaf et al., 2011</a>; <a href="#bib55" class="usa-link" aria-describedby="bib55">Turnbull et al., 2014</a>) might also improve the overall predictability of the method.</p>
<p>Our data illustrate the potential of iPSCs technology for the prediction of individual risk and for its use in precision medicine. We found a limited number of lines with discrepant results in vitro as compared to the clinical phenotype, suggesting a good accuracy of the approach. However, as we only investigated patients with extreme responses to sotalol, our study was not designed to accurately assess the predictive value of the test. This should be adequately addressed in larger prospective studies.</p>
<p>In conclusion, this study underscores the power of developing a panel of iPSCs to model complex traits such as susceptibility to develop cardiotoxic drug response.</p></section><section id="s4"><h2 class="pmc_sec_title">Material and methods</h2>
<section id="s4-1"><h3 class="pmc_sec_title">Subjects and clinical investigations</h3>
<p>To participate to the study, male or female volunteers had to fulfill the following inclusion criteria: aged 18 to 40 years, body mass index from 19 to 29 kg/m<sup>2</sup>, no previous history of cardiac disease, no major disorders, no medications known to affect cardiac repolarization (as defined by <a href="https://www.crediblemeds.org/everyone/composite-list-all-qtdrugs" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.crediblemeds.org/everyone/composite-list-all-qtdrugs</a>). All volunteers had normal laboratory evaluations and a normal clinical examination with a resting heart rate ≥50 beats min<sup>−1</sup> and a systolic blood pressure ≥100 mmHg. Cardiac conduction and repolarization was assessed on a 12-lead resting electrocardiogram and participants were excluded in case of atrio-ventricular conduction disorder (PR interval &gt;200 ms), QRS &gt;100 ms and in case of prolonged QTcF &gt;450 ms. Other exclusion criteria were familial or personal history of sudden death or unexplained syncope, concomitant use of illicit drugs, asthma.</p>
<p>The protocol was approved by the local institutional ethics committee and all subjects gave their written informed consent for participation to the study.</p>
<p>All investigations were performed prospectively at a single clinical center (Biotrial Paris, Rueil Malmaison, France). In a first phase, eligible subjects were admitted at 7:30am at the clinical investigation center after an overnight fast. Subjects were placed in a quiet room and rested for 30 min in the supine position. Cardiac rhythm and non-invasive blood pressure monitoring were started. The quality of ECG recordings was assessed and baseline recordings were performed during the 5 min preceding sotalol oral administration (80 mg tablet). ECG recordings were then performed 3 hr after sotalol intake, i.e. around peak plasma concentration. Blood samples for the determination of sotalol concentration were obtained at baseline and 3 hr after sotalol administration. Volunteers were allowed to leave the clinical investigation center 5 hr after sotalol intake after cardiac repolarization had normalized.</p>
<p>In a second phase (7 to 35 days after phase 1), 20 subjects with the most extreme responses to sotalol (10 with smallest QTcF changes and 10 with the largest QTcF changes from baseline in response to sotalol) were asked to come to the clinical investigation center and had a skin biopsy under local anesthesia using a sterile 3 mm skin punch.</p></section><section id="s4-2"><h3 class="pmc_sec_title">ECG recording and analysis</h3>
<p>Before and 3 hr following sotalol administration, 30 s digital 12-lead electrocardiograms were recorded using a Cardioplug device (Cardionics Inc, Brussels, Belgium) connected to a personal computer. All electrocardiogram recordings were then read by the same investigator, blindly of drug administration. The same chest lead with the largest T-wave amplitude was selected for QT interval measurements in a given subject. QT interval was measured manually directly on the computer screen by changing position of cursors indicating the start and the end of the cardiac interval: RR (interval between two successive R waves) and QT (tangent method). Baseline QTc was assessed as the mean of three electrocardiographic recordings obtained within 5 min before drug administration. QT was corrected by the Fridericia cubic root formula (QTcf), which minimizes the errors due to the square root Bazett formula. The clinical phenotype was defined by modifications in QTcf duration (ms) 3 hr after sotalol intake.</p></section><section id="s4-3"><h3 class="pmc_sec_title">Human iPSCs derivation</h3>
<p>Fibroblast derivation was performed immediately after biopsy arrival at Ectycell / Cellectis Stem Cell Company (Evry, France). Skin biopsy of a 3 mm diameter punch was cut into about 20 small explants with scalpels and placed in 6-well plates and cultured with fibroblast growth medium containing DMEM medium (Gibco), 10% of FBS (PAA Laboratories), 10 ng/ml FGF-2 (Invitrogen, Carlsbad, CA) and 1% penicillin-streptomycin (Gibco). Cells were fed every 2–3 days. In this culture, fibroblasts appeared and became confluent on average 33 days after plating. The fibroblasts were then subcultured using 0.25% trypsin (Invitrogen) then re-suspended and cultured into T75 flasks using fibroblast growth medium without antibiotics. An average of 62 million fibroblasts per biopsy was obtained in 4–7 weeks at passage 1. The fibroblasts were tested for mycoplasma contamination and no contamination was detected (MycoAlert TM Mycoplasma Detection kit, Lonza France).</p>
<p>Reprogramming of fibroblasts derived from patient’s skin biopsies into iPSCs was carried out using polycistronic retroviral vectors. The fibroblasts were seeded in 6-well plates at a defined cell density (100,000 cells/well) and cultured with fibroblast growth medium (DMEM medium containing 10% of FBS and 10 ng/ml FGF-2). For transduction, cells were incubated with polycistronic retroviral vectors (provided by Vectalys, Toulouse, France) carrying human Oct4, Sox2, Klf4, and c-Myc (OSKM) expression factors in fibroblast medium supplemented with 6 µg/ml polybrene (Sigma, St Louis, MO) overnight. The cells were transduced at a multiplicity of infection of 5. Four days post-infection, the cells were split by using 0.25% trypsin and plated at 100,000 cell/well in 0.1% gelatin-coated 6-well plates in fibroblast growth medium. After 24 hr, the medium was switched to the human pluripotent stem cell medium (DMEM/F12, 20% knockout serum replacement, 1× non-essential amino acid, 2 mM L-glutamine, 0.1 mM 2-mercaptoethanol, 20 ng/ml FGF-2 and 1% penicillin-streptomycin) with 0.5 mM Valproic acid (VPA). The media were changed every day. Around 20–25 days post-infection, the human ESC-like colonies appeared. The iPSCs colonies were picked and expanded in mTeSR1 (Stemcell technologies, Canada) on matrigel matrix (BD Biosciences France) coated plates. The iPSCs were passaged with Accutase (10 ml pre 75 cm2 surface area, Millipore, Billerica, MA) and the culture medium was changed daily.</p>
<p>Colonies fulfilling established ‘stemness’ criteria were selected and sent to the Cardiovascular Research Center at Mount Sinai School of Medicine, New York, USA for differentiation toward the cardiomyocyte lineage and pharmacological characterization.</p></section><section id="s4-4"><h3 class="pmc_sec_title">Differentiation of iPSCs into cardiomyocytes</h3>
<p>The iPSCs were differentiated into cardiomyocytes using a directed differentiation method. Cardiomyocytes differentiation was initiated in suspension cultures on ultra-low attachment dishes (Corning, France) in mTESR1 medium supplemented with BMP4 10 ng ml-1) and Blebbistatin (5 μM) for 24 hr. The medium was then replaced with the basal differentiation medium (StemPro34, 50 μg ml-1 ascorbic acid, 2 mM GlutaMAX-I) supplemented with BMP4 (10 ng ml-1) and Activin-A (25 ng ml-1) for 48 hr (days 1–3) and then switched to basal differentiation medium for another 36 hr (days 3–4.5). Finally, the cells were differentiated in basal differentiation medium supplemented with IWR-1 (2.5 μM) for 96 hr (Day 4.5–8.5). The differentiated cardiomyocytes were maintained in basal differentiation media for up to four weeks. All cytokines were purchased from R and D. The small molecules were purchased from Sigma. All differentiation cultures were maintained in 5% CO2/air environment.</p></section><section id="s4-5"><h3 class="pmc_sec_title">Immunocytochemistry</h3>
<p>iPSCs were cultured on matrigel-coated coverslips, fixed in paraformaldehyde and permeabilized in blocking/permeabilization buffer (2% BSA/2% FBS/0.05% NP-40 in PBS) for 45 min and incubated with primary antibodies overnight at 4°C. Then the cells were washed in PBS and incubated with Alexa-conjugated secondary antibodies (Invitrogen) diluted in blocking/permeabilization buffer (1:750). Finally, after washing in PBS the cells were counterstained with DAPI. Immunofluorescence images were acquired using an Olympus X41 microscope. The following antibodies were used: mouse monoclonal anti-OCT4 (Santa Cruz biotechnology, Germany), goat polyclonal anti-NANOG (R and D systems), mouse monoclonal anti-SOX2 (R and D systems), mouse monoclonal anti-SSEA-4 (R and D systems, Minneapolis, MN), mouse monoclonal anti-TRA-1–60 (R and D systems). Similarly, iPSC-derived cardiomyocytes were dissociated and cultured on matrigel-coated coverslips for 4–5 days, fixed in paraformaldehyde and permeabilized in blocking/permeabilization buffer for 45 min. The following primary antibodies were used: mouse monoclonal anti-cardiac troponin T (Thermo Fisher Scientific, France), mouse monoclonal anti-connexin 43, and mouse monoclonal anti-α-actinin. Confocal imaging was performed using a Leica SP5 confocal system.</p></section><section id="s4-6"><h3 class="pmc_sec_title">Flow cytometry</h3>
<p>Single-cell suspensions were obtained by dissociating EBs with 0.025% trypsin for 15 min at 37°C. The cells were then fixed with 4% paraformaldehyde for 15 min and washed twice with phosphate buffered saline (PBS). The fixed cells were first permeabilized in permeabilization buffer (0.2% Triton X-100 in PBS) for 30 min and then blocked with 10% goat serum for 25 min. Cells were then incubated with the primary antibody (anti-cardiac troponin T; Thermo Fisher Scientific). After 1 hr, the cells were washed in PBS, incubated with Goat anti-mouse IgG1 - Alexa 488 secondary antibody for 45 min, and finally washed twice with PBS. All procedures were performed at 4°C. Fluorescence-activated cell sorting analysis was carried out using a BD LSR analyzer (BD Biosciences).</p></section><section id="s4-7"><h3 class="pmc_sec_title">Quantitative PCR</h3>
<p>Relative gene expression was determined using a two-steps quantitative real-time PCR method. Total RNA was isolated with the RNeasy Isolation kit with on-column DNase I treatment (Qiagen, Germany) and reverse-transcribed using the cDNA Synthesis Kit (Biorad, Hercules, CA). Quantitative RT-PCR was performed with the Quanta SYBR Green Supermix (Quanta biosciences, Beverly, MA) on the ABI Prism 7500 Real Time PCR System (Applied Biosystems, Foster City, CA). Fold changes in gene expression were determined using the comparative CT method (△△Ct) with normalization to the housekeeping gene B2M.</p></section><section id="s4-8"><h3 class="pmc_sec_title">SNPs genotyping array</h3>
<p>Single nucleotide polymorphism (SNP) genotyping analysis was performed using the Illumina HumanOmni2.5–8 beadchip genotyping array, which comprise a comprehensive set of around 2.6 million SNPs (with MAF &gt;2.5%) across the genome. The list of mapped SNPs can be found at <a href="http://support.illumina.com/downloads/infinium-omni2-5-8-v1-3-support-files.html." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://support.illumina.com/downloads/infinium-omni2-5-8-v1-3-support-files.html.</a> All genomic DNA was isolated from iPSC clones using Quick-gDNA Mini Prep kit (Zymo Research, Irvine, CA). Input genomic DNA (200 ng) was processed, hybridized to the array and scanned on an Illumina HiScan at the Mount Sinai Genomic Core Facility. Based on chromosome coordinates, we extracted SNPs in <em>AKAP9, ANK2, CACNA1C, CALM1, CALM2, CAV3, KCNH2, KCNE1, KCNE2, KCNJ2, KCNJ5, KCNQ1, SCN4B, SCN5A, SNTA1</em> using Genome Studio (Illumina, San Diego, CA). Genotypes were estimated and compared between low-S and high-S groups. We used HapMap-CEU data to estimate the anticipated minor allelic frequency in European population.</p></section><section id="s4-9"><h3 class="pmc_sec_title">RNA-Sequencing</h3>
<p>Total RNA was extracted using Zymo columns and 2 µg were used to generate a RNA-seq sequencing library. Poly-A selection and mRNA-SEQ library preparation were performed at the Mount Sinai Genomics Core Facility. Sequencing (50 bases, paired ends) was performed using an Illumina HiSeq2500. Annotated reads were obtained using STAR and HTSeq and normalized to full library size.</p>
<p>Sequencing reads were aligned to the human reference genome 'hg19' using Tophat 2.0.8 (<a href="#bib53" class="usa-link" aria-describedby="bib53">Trapnell et al., 2009</a>), samtools-0.1.7 and bowtie 2.1.0 (<a href="#bib22" class="usa-link" aria-describedby="bib22">Langmead and Salzberg, 2012</a>) and differentially expressed genes were identified with cufflinks 1.3.0 (<a href="#bib54" class="usa-link" aria-describedby="bib54">Trapnell et al., 2010</a>).</p>
<p>The total number of sequenced reads in a sample influences the likelihood to detect a lowly to moderately expressed gene, especially in case of lower read counts (<a href="#bib31" class="usa-link" aria-describedby="bib31">McIntyre et al., 2011</a>). In consequence, it could happen that fewer genes are detected in a sample with a lower read count than in a sample with a higher read count. Such an experimental artifact might distort normalization including total reads as well as upper quartile normalization, the two normalization options that are offered by cufflinks. Both normalization approaches only change the number of reads that are associated with a gene, but not the number of identified genes. Consequently, the same number of normalized reads might be distributed over a different number of genes in two different samples, causing the detection of an equally expressed gene in both samples as differentially expressed. To prevent such an experimental artifact we randomly removed reads from the sequenced samples until every sample had the same number of read counts. Reads were aligned to the human reference genome hg19 with Tophat using the ensemble GTF file as a gene annotation reference and the option 'no-novel-juncs'. Output BAM files were directly subjected to Cufflinks to identify differentially expressed genes, using the options 'multi-read-correct', 'upper-quartile-norm' and 'frag-bias-correct' against the hg19 genome. Differentially expressed genes were identified based on a FDR of 5% and a minimum fold change (log<sub>2</sub>((FPKM<sub>condition1</sub>+1)/(FPKM<sub>condition2</sub> + 1)) &gt;= ± log<sub>2</sub>(1.3)).</p>
<p>We determined differentially expressed genes between the high-S (P11008, P11013, <a href="https://www.ncbi.nlm.nih.gov/protein/P11015" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11015</a>, <a href="https://www.ncbi.nlm.nih.gov/protein/P11018" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11018</a>, <a href="https://www.ncbi.nlm.nih.gov/protein/P11019" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11019</a>, <a href="https://www.ncbi.nlm.nih.gov/protein/P11021" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11021</a>, <a href="https://www.ncbi.nlm.nih.gov/protein/P11023" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11023</a>, <a href="https://www.ncbi.nlm.nih.gov/protein/P11024" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11024</a>, <a href="https://www.ncbi.nlm.nih.gov/protein/P11029" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11029</a>) and the low-S (<a href="https://www.ncbi.nlm.nih.gov/protein/P11007" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11007</a>, <a href="https://www.ncbi.nlm.nih.gov/protein/P11009" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11009</a>, <a href="https://www.ncbi.nlm.nih.gov/protein/P11014" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11014</a>, <a href="https://www.ncbi.nlm.nih.gov/protein/P11020" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11020</a>, <a href="https://www.ncbi.nlm.nih.gov/protein/P11026" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11026</a>, <a href="https://www.ncbi.nlm.nih.gov/protein/P11028" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11028</a>, <a href="https://www.ncbi.nlm.nih.gov/protein/P11030" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11030</a>, <a href="https://www.ncbi.nlm.nih.gov/protein/P11031" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P11031</a>) cell lines. To compare gene expression values of the identified candidates across individual samples, we subjected all samples as individual conditions to the cufflinks analysis pipeline in the same way as described above. We used the FPKM values of the cufflinks results file as a measure for normalized gene expression.</p>
<p>To analyze, if differentially expressed genes between the high-S and low-S group are caused by gender differences between the two groups, we generated all possible combinations of one high-S female and one low-S female (16 groups) and one high-S male and one low-S male (six groups). We determined differentially expressed genes between all possible combinations of one female group versus one male group (16 × 6 sets of DEGs). For each gene we counted in how many sets of DEGs it was detected as significantly up-regulated or down-regulated, subtracted the counts for down-regulated detections from the counts for up-regulated detections and divided the resulting number by the counts for sets of DEGs (i.e. by 96).</p></section><section id="s4-10"><h3 class="pmc_sec_title">Network analysis and direct neighbors identification</h3>
<p>To search for differentially expressed direct neighbors of LQTS disease genes, we generate a human interactome by merging all protein-protein interaction databases of the Expression2 kinases suite (<a href="#bib7" class="usa-link" aria-describedby="bib7">Chen et al., 2012</a>), except the 'Predicted PPI' database, and a recently published protein-protein interaction network (<a href="#bib45" class="usa-link" aria-describedby="bib45">Rolland et al., 2014</a>). Small letter symbols of the merged interactome were replaced by their human homologues, using the Mouse Genome Informatics mouse-human orthology database and the NCBI mouse-human homologene database. Finally, we removed all network nodes that were not official human gene symbols as reported in the NCBI geneInfo database. Differentially expressed genes in the direct neighborhood of LQTS disease genes ('AKAP9', 'ANK2', 'CACNA1C', 'CALM1', 'CALM2', 'CAV3', 'KCNE1', 'KCNE2', 'KCNH2', 'KCNJ2', 'KCNJ5', 'KCNQ1', 'SCN4B', 'SCN5A', 'SNTA1') were identified (path length = 1).</p></section><section id="s4-11"><h3 class="pmc_sec_title">Prediction of upstream regulatory transcription factors</h3>
<p>All differentially expressed genes were subjected to transcription factor target enrichment analysis using the Chea-background and Transfac database (downloaded from EnrichR [<a href="#bib6" class="usa-link" aria-describedby="bib6">Chen et al., 2013</a>]), as described previously (<a href="#bib20" class="usa-link" aria-describedby="bib20">Karakikes et al., 2014</a>).</p></section><section id="s4-12"><h3 class="pmc_sec_title">Extracellular field potential recordings (MEA assay)</h3>
<p>For MEA recordings, we used 6well-MEA arrays, which contain six independent culture chambers, separated by a macrolon ring (60–6 well MEA 200/30 iR-Ti-rcr, Multichannel Systems, Germany). Inside each well, there is a field of nine electrodes with an internal reference electrode (<a href="#fig2s2" class="usa-link">Figure 2—figure supplement 2</a>). The 6well-MEA arrays were prepared by pipetting 5 μl fibronectin solution (100 μg/mL, BD Biosciences) and incubated at 37°C for at least 1 hr. iPSC-CMs were dissociated using 0.025% trypsin for 5 min at 37°C and seeded onto prepared MEA plates using 5 μl of cell suspension in StemPro34 medium and then incubated at 37°C/5% CO2. The day after the cells were covered with 200 µL of StemPro34 media. MEA recordings were performed once the cells started to beat again (5–7 days). Field potentials of spontaneously beating cardiomyocytes were recorded using a high-resolution Micro Electrode Array (MEA) recording system (MEA60 system, Multi Channel Systems, Reutlingen, Germany, <a href="http://www.multichannelsystems.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.multichannelsystems.com</a>) at 37°C. The baseline steady state was achieved following an equilibration period of about 15 min in vehicle medium (StemPro34 media). The tested drugs (E4031 and Sotalol, Sigma) were then added directly to each well. Dose-response experiments were performed with the following sequence: drugs were diluted in 200 μL of StemPro34 media; increasing concentrations of drug were added to a well of the MEA array in a cumulative manner; the FPD recordings were started 3 min after application of a given concentration of a drug, a timing that was found optimal to achieve steady-state changes; FPD recordings were then performed for two additional minutes. Each drug was tested in at least three different wells. Raw MEA data were acquired using QT-Screen Lite and MC-Rack softwares (Multi Channel Systems, Reutlingen, Germany). The data were then exported on QT-Analyzer Software to analyze the field potential duration and the inter-beat interval (Multi Channel Systems, Reutlingen, Germany). Parameters were averaged on the 2 min recordings. Inter-beat interval (in ms) was used to calculate the instantaneous beat rate. To account for the dependency between repolarization rate and the beating rate, FPD was firstly adjusted using the popular Bazett’s formula (adjustedFPD = rawFPD / RR1/2). We however found that, as expected, this formula was associated with an important over-correction thus supporting the need for an alternative adjustment formula according to Funck-Brentano et al. (<a href="#bib12" class="usa-link" aria-describedby="bib12">Funck-Brentano and Jaillon, 1993</a>) (<a href="#fig2s3" class="usa-link">Figure 2—figure supplement 3</a>, panel A). We thus plotted the FPD / inter-beat-interval pairs recorded at various beating rates under baseline conditions. The following equation with the same dimension as a Bazett’s formula: adjustedFPD = rawFPD / RRα, where alpha is a regression parameter, was applied to raw data in order to have a new estimate of the correction factor and results in appropriate corrections of FPD (<a href="#fig2s3" class="usa-link">Figure 2—figure supplement 3</a>, panel B).</p>
<p>Cells were considered as developing arrhythmias in response to sotalol as they presented ectopic beats or spontaneous beating rates became irregular.</p></section><section id="s4-13"><h3 class="pmc_sec_title">Patch clamp recordings</h3>
<p>hiPSC-derived embryoid bodies were enzymatically dissociated into single cardiomyocytes and plated on matrigel-coated glass coverslips. The action potential of cardiomyocytes was assessed in the current-clamp mode using whole-cell patch-clamp technique with a HEKA EPC10 amplifier and Pulse/PulseFit software (HEKA, Germany). Pipette solution consisted of: 110 mM potassium aspartate, 20 mM KCl, 10 mM HEPES, 1 mM MgCl2, 0.1 mM ATP (disodium salt), 5 mM ATP (magnesium salt), 5 mM phosphocreatine (disodium salt) and 1 mM EGTA (pH 7.2). The external bath solution contained 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 10 mM D-glucose, 1 mM CaCl2 and 10 mM HEPES (pH 7.4). hiPSC-CMs were perfused with either control or sotalol-containing Tyrode's solution for 5 min. The whole-cell condition was then reached. A hyperpolarization current (−30 pA) was applied to silence the spontaneous automaticity. The AP recording was then performed with a train of current pulse injection (1000 pA, 5 ms) at 0.5 Hz steady pacing. The assay was performed at 37°C and finished within 30 min upon the drug perfusion.</p></section><section id="s4-14"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>All analyses were performed using Prism 6.0 (GraphPad, La Jolla, CA). Continuous data are presented as Mean ± SEM. A p-value≤0.05 was considered significant. Continuous variables were compared using non-parametric Mann-Whitney test and binary variables were tested using Chi-square or exact Fisher’s test as appropriate. For the in vivo investigations, we planned to identify 20 extreme responders to sotalol (i.e., 10 with high response defined by a deltaQTcf &gt;35 ms and 10 with low response defined by a deltaQTcf &lt;5 ms, therefore defining a minimal difference of 30 ms between groups). We then anticipated that this in vivo difference will be reproduced in vitro with a reduction by 33%. We thus determined that this sample size will give 80% power to demonstrate a difference of 20 ms between groups, with a standard error of 15 ms and an alpha-error risk of 0.05 (nQuery Advisor version 4.0).</p>
<p>Responses to drugs, as measured in vitro, were normalized to baseline values and expressed as changes to baseline to account for inter-line variability. All recorded data were analyzed. A two-way analysis of variance with repeated measures was performed to analyze response to sotalol. Sotalol concentrations define the first factor and the sensitivity group the second factor. Individual comparisons were performed when the overall analysis was significant. Dose response curves were built to estimate EC50 using the Hill equation.</p></section></section><section id="s5"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We thank the Biotrial core lab. This work was funded by the Cellectis Company. JH and RI are supported by NIH P50 GM071558 and GM54508 and U54 <a href="https://www.ncbi.nlm.nih.gov/nuccore/HG008098" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">HG008098</a>.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</p></section><section id="sec25"><h2 class="pmc_sec_title">Funding Information</h2>
<p>This paper was supported by the following grants:</p>
<ul class="list" style="list-style-type:disc">
<li><p>National Institutes of Health
P50 GM071558 to Jens Hansen, Ravi Iyengar.</p></li>
<li><p>National Institutes of Health
GM54508 to Jens Hansen, Ravi Iyengar.</p></li>
<li><p>National Institutes of Health
U54 HG008098 to Jens Hansen, Ravi Iyengar.</p></li>
<li><p>Cellectis Company
Research subvention to Jean-Sébastien Hulot.</p></li>
</ul></section><section id="s6"><h2 class="pmc_sec_title">Additional information</h2>
<section id="fn-group1" class="fn-group"><h3 class="pmc_sec_title"><strong>Competing interests</strong></h3>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="conf2"><p>SR: Current or former employee of the Cellectis Company.</p></div>
<div class="fn p" id="conf3"><p>MW: Current or former employee of the Cellectis Company.</p></div>
<div class="fn p" id="conf4"><p>YV: Current or former employee of the Cellectis Company.</p></div>
<div class="fn p" id="conf5"><p>CD: Current or former employee of the Cellectis Company.</p></div>
<div class="fn p" id="conf1"><p>The other authors declare that no competing interests exist.</p></div>
</div></section><section id="fn-group2" class="fn-group"><h3 class="pmc_sec_title"><strong>Author contributions</strong></h3>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="con1"><p>FS, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article.</p></div>
<div class="fn p" id="con2"><p>JH, Analysis and interpretation of data, Drafting or revising the article.</p></div>
<div class="fn p" id="con3"><p>C-WK, Acquisition of data, Analysis and interpretation of data.</p></div>
<div class="fn p" id="con4"><p>IK, Acquisition of data, Drafting or revising the article.</p></div>
<div class="fn p" id="con5"><p>CF-B, Analysis and interpretation of data, Drafting or revising the article.</p></div>
<div class="fn p" id="con6"><p>LG, Acquisition of data, Analysis and interpretation of data.</p></div>
<div class="fn p" id="con7"><p>SS, Acquisition of data, Drafting or revising the article.</p></div>
<div class="fn p" id="con8"><p>SR, Acquisition of data, Drafting or revising the article.</p></div>
<div class="fn p" id="con9"><p>MW, Acquisition of data, Drafting or revising the article.</p></div>
<div class="fn p" id="con10"><p>YV, Acquisition of data, Contributed unpublished essential data or reagents.</p></div>
<div class="fn p" id="con11"><p>CD, Conception and design, Contributed unpublished essential data or reagents.</p></div>
<div class="fn p" id="con12"><p>J-ES, Analysis and interpretation of data, Drafting or revising the article.</p></div>
<div class="fn p" id="con13"><p>DJ, Acquisition of data, Drafting or revising the article.</p></div>
<div class="fn p" id="con14"><p>NZ, Acquisition of data, Drafting or revising the article.</p></div>
<div class="fn p" id="con15"><p>RL, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article.</p></div>
<div class="fn p" id="con16"><p>RI, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article.</p></div>
<div class="fn p" id="con17"><p>RJH, Conception and design, Analysis and interpretation of data, Drafting or revising the article.</p></div>
<div class="fn p" id="con18"><p>J-SH, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article.</p></div>
</div></section><section id="fn-group3" class="fn-group"><h3 class="pmc_sec_title"><strong>Ethics</strong></h3>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1"><p>Clinical trial registration clinicaltrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT01338441" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01338441</a>.</p></div>
<div class="fn p" id="fn2"><p>Human subjects: The protocol was approved by local institutional ethics committee (CPP Ile de France XI 11-015 &amp; Afssaps A110094-37) and all subjects gave their written informed consent for participation to the study.</p></div>
</div></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ol class="ref-list font-sm">
<li id="bib1">
<cite>Behr ER, Roden D. Drug-induced arrhythmia: pharmacogenomic prescribing? European Heart Journal. 2013;34:89–95. doi: 10.1093/eurheartj/ehs351.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehs351" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3538275/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23091201/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Heart%20Journal&amp;title=Drug-induced%20arrhythmia:%20pharmacogenomic%20prescribing?&amp;author=ER%20Behr&amp;author=D%20Roden&amp;volume=34&amp;publication_year=2013&amp;pages=89-95&amp;pmid=23091201&amp;doi=10.1093/eurheartj/ehs351&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib2">
<cite>Berger SI, Ma'ayan A, Iyengar R. Systems pharmacology of arrhythmias. Science Signaling. 2010;3:ra30.  doi: 10.1126/scisignal.2000723.</cite> [<a href="https://doi.org/10.1126/scisignal.2000723" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3068558/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20407125/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science%20Signaling&amp;title=Systems%20pharmacology%20of%20arrhythmias&amp;author=SI%20Berger&amp;author=A%20Ma'ayan&amp;author=R%20Iyengar&amp;volume=3&amp;publication_year=2010&amp;pages=ra30&amp;pmid=20407125&amp;doi=10.1126/scisignal.2000723&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib3">
<cite>Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA. 2006;296:1858–1866. doi: 10.1001/jama.296.15.1858.</cite> [<a href="https://doi.org/10.1001/jama.296.15.1858" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17047216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=National%20surveillance%20of%20emergency%20department%20visits%20for%20outpatient%20adverse%20drug%20events&amp;author=DS%20Budnitz&amp;author=DA%20Pollock&amp;author=KN%20Weidenbach&amp;author=AB%20Mendelsohn&amp;author=TJ%20Schroeder&amp;volume=296&amp;publication_year=2006&amp;pages=1858-1866&amp;pmid=17047216&amp;doi=10.1001/jama.296.15.1858&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib4">
<cite>Burridge PW, Matsa E, Shukla P, Lin ZC, Churko JM, Ebert AD, Lan F, Diecke S, Huber B, Mordwinkin NM, Plews JR, Abilez OJ, Cui B, Gold JD, Wu JC. Chemically defined generation of human cardiomyocytes. Nature Methods. 2014;11:855–860. doi: 10.1038/nmeth.2999.</cite> [<a href="https://doi.org/10.1038/nmeth.2999" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4169698/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24930130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Methods&amp;title=Chemically%20defined%20generation%20of%20human%20cardiomyocytes&amp;author=PW%20Burridge&amp;author=E%20Matsa&amp;author=P%20Shukla&amp;author=ZC%20Lin&amp;author=JM%20Churko&amp;volume=11&amp;publication_year=2014&amp;pages=855-860&amp;pmid=24930130&amp;doi=10.1038/nmeth.2999&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib5">
<cite>Cerrone M, Priori SG. Genetics of sudden death: focus on inherited channelopathies. European Heart Journal. 2011;32:2109–2118. doi: 10.1093/eurheartj/ehr082.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehr082" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21478491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Heart%20Journal&amp;title=Genetics%20of%20sudden%20death:%20focus%20on%20inherited%20channelopathies&amp;author=M%20Cerrone&amp;author=SG%20Priori&amp;volume=32&amp;publication_year=2011&amp;pages=2109-2118&amp;pmid=21478491&amp;doi=10.1093/eurheartj/ehr082&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib6">
<cite>Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma'ayan A. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128.  doi: 10.1186/1471-2105-14-128.</cite> [<a href="https://doi.org/10.1186/1471-2105-14-128" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3637064/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23586463/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Bioinformatics&amp;title=Enrichr:%20interactive%20and%20collaborative%20HTML5%20gene%20list%20enrichment%20analysis%20tool&amp;author=EY%20Chen&amp;author=CM%20Tan&amp;author=Y%20Kou&amp;author=Q%20Duan&amp;author=Z%20Wang&amp;volume=14&amp;publication_year=2013&amp;pages=128&amp;pmid=23586463&amp;doi=10.1186/1471-2105-14-128&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib7">
<cite>Chen EY, Xu H, Gordonov S, Lim MP, Perkins MH, Ma'ayan A. Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layers. Bioinformatics. 2012;28:105–111. doi: 10.1093/bioinformatics/btr625.</cite> [<a href="https://doi.org/10.1093/bioinformatics/btr625" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3244772/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22080467/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Expression2Kinases:%20mRNA%20profiling%20linked%20to%20multiple%20upstream%20regulatory%20layers&amp;author=EY%20Chen&amp;author=H%20Xu&amp;author=S%20Gordonov&amp;author=MP%20Lim&amp;author=MH%20Perkins&amp;volume=28&amp;publication_year=2012&amp;pages=105-111&amp;pmid=22080467&amp;doi=10.1093/bioinformatics/btr625&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib8">
<cite>Cirulli ET, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nature Reviews Genetics. 2010;11:415–425. doi: 10.1038/nrg2779.</cite> [<a href="https://doi.org/10.1038/nrg2779" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20479773/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews%20Genetics&amp;title=Uncovering%20the%20roles%20of%20rare%20variants%20in%20common%20disease%20through%20whole-genome%20sequencing&amp;author=ET%20Cirulli&amp;author=DB%20Goldstein&amp;volume=11&amp;publication_year=2010&amp;pages=415-425&amp;pmid=20479773&amp;doi=10.1038/nrg2779&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib9">
<cite>Crotti L, Johnson CN, Graf E, De Ferrari GM, Cuneo BF, Ovadia M, Papagiannis J, Feldkamp MD, Rathi SG, Kunic JD, Pedrazzini M, Wieland T, Lichtner P, Beckmann BM, Clark T, Shaffer C, Benson DW, Kääb S, Meitinger T, Strom TM, Chazin WJ, Schwartz PJ, George AL. Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation. 2013;127:1009–1017. doi: 10.1161/CIRCULATIONAHA.112.001216.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.112.001216" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3834768/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23388215/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Calmodulin%20mutations%20associated%20with%20recurrent%20cardiac%20arrest%20in%20infants&amp;author=L%20Crotti&amp;author=CN%20Johnson&amp;author=E%20Graf&amp;author=GM%20De%20Ferrari&amp;author=BF%20Cuneo&amp;volume=127&amp;publication_year=2013&amp;pages=1009-1017&amp;pmid=23388215&amp;doi=10.1161/CIRCULATIONAHA.112.001216&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib10">
<cite>Darpo B, Karnad DR, Badilini F, Florian J, Garnett CE, Kothari S, Panicker GK, Sarapa N. Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol. British Journal of Clinical Pharmacology. 2014;77:522–531. doi: 10.1111/bcp.12201.</cite> [<a href="https://doi.org/10.1111/bcp.12201" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4371537/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23819796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Clinical%20Pharmacology&amp;title=Are%20women%20more%20susceptible%20than%20men%20to%20drug-induced%20QT%20prolongation?%20Concentration-QTc%20modelling%20in%20a%20phase%201%20study%20with%20oral%20rac-sotalol&amp;author=B%20Darpo&amp;author=DR%20Karnad&amp;author=F%20Badilini&amp;author=J%20Florian&amp;author=CE%20Garnett&amp;volume=77&amp;publication_year=2014&amp;pages=522-531&amp;pmid=23819796&amp;doi=10.1111/bcp.12201&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib11">
<cite>Fermini B, Fossa AA. The impact of drug-induced QT interval prolongation on drug discovery and development. Nature Reviews Drug Discovery. 2003;2:439–447. doi: 10.1038/nrd1108.</cite> [<a href="https://doi.org/10.1038/nrd1108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12776219/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews%20Drug%20Discovery&amp;title=The%20impact%20of%20drug-induced%20QT%20interval%20prolongation%20on%20drug%20discovery%20and%20development&amp;author=B%20Fermini&amp;author=AA%20Fossa&amp;volume=2&amp;publication_year=2003&amp;pages=439-447&amp;pmid=12776219&amp;doi=10.1038/nrd1108&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib12">
<cite>Funck-Brentano C, Jaillon P. Rate-corrected QT interval: techniques and limitations. The American Journal of Cardiology. 1993;72:17B–22. doi: 10.1016/0002-9149(93)90035-B.</cite> [<a href="https://doi.org/10.1016/0002-9149(93)90035-B" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8256750/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20American%20Journal%20of%20Cardiology&amp;title=Rate-corrected%20QT%20interval:%20techniques%20and%20limitations&amp;author=C%20Funck-Brentano&amp;author=P%20Jaillon&amp;volume=72&amp;publication_year=1993&amp;pages=17B-22&amp;pmid=8256750&amp;doi=10.1016/0002-9149(93)90035-B&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib13">
<cite>Gintant G. An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation. Pharmacology &amp; Therapeutics. 2011;129:109–119. doi: 10.1016/j.pharmthera.2010.08.008.</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2010.08.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20807552/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology%20&amp;%20Therapeutics&amp;title=An%20evaluation%20of%20hERG%20current%20assay%20performance:%20Translating%20preclinical%20safety%20studies%20to%20clinical%20QT%20prolongation&amp;author=G%20Gintant&amp;volume=129&amp;publication_year=2011&amp;pages=109-119&amp;pmid=20807552&amp;doi=10.1016/j.pharmthera.2010.08.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib14">
<cite>Giorgi MA, Bolaños R, Gonzalez CD, Di Girolamo G. QT interval prolongation: preclinical and clinical testing arrhythmogenesis in drugs and regulatory implications. Current Drug Safety. 2010;5:54–57. doi: 10.2174/157488610789869148.</cite> [<a href="https://doi.org/10.2174/157488610789869148" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20210719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Drug%20Safety&amp;title=QT%20interval%20prolongation:%20preclinical%20and%20clinical%20testing%20arrhythmogenesis%20in%20drugs%20and%20regulatory%20implications&amp;author=MA%20Giorgi&amp;author=R%20Bola%C3%B1os&amp;author=CD%20Gonzalez&amp;author=G%20Di%20Girolamo&amp;volume=5&amp;publication_year=2010&amp;pages=54-57&amp;pmid=20210719&amp;doi=10.2174/157488610789869148&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib15">
<cite>Hulot JS, Démolis JL, Rivière R, Strabach S, Christin-Maitre S, Funck-Brentano C. Influence of endogenous oestrogens on QT interval duration. European Heart Journal. 2003;24:1663–1667. doi: 10.1016/S0195-668X(03)00436-6.</cite> [<a href="https://doi.org/10.1016/S0195-668X(03)00436-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14499229/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Heart%20Journal&amp;title=Influence%20of%20endogenous%20oestrogens%20on%20QT%20interval%20duration&amp;author=JS%20Hulot&amp;author=JL%20D%C3%A9molis&amp;author=R%20Rivi%C3%A8re&amp;author=S%20Strabach&amp;author=S%20Christin-Maitre&amp;volume=24&amp;publication_year=2003&amp;pages=1663-1667&amp;pmid=14499229&amp;doi=10.1016/S0195-668X(03)00436-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib16">
<cite>Inoue H, Yamanaka S. The use of induced pluripotent stem cells in drug development. Clinical Pharmacology &amp; Therapeutics. 2011;89:655–661. doi: 10.1038/clpt.2011.38.</cite> [<a href="https://doi.org/10.1038/clpt.2011.38" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21430656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Pharmacology%20&amp;%20Therapeutics&amp;title=The%20use%20of%20induced%20pluripotent%20stem%20cells%20in%20drug%20development&amp;author=H%20Inoue&amp;author=S%20Yamanaka&amp;volume=89&amp;publication_year=2011&amp;pages=655-661&amp;pmid=21430656&amp;doi=10.1038/clpt.2011.38&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib17">
<cite>Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A, Feldman O, Gepstein A, Arbel G, Hammerman H, Boulos M, Gepstein L. Modelling the long QT syndrome with induced pluripotent stem cells. Nature. 2011;471:225–229. doi: 10.1038/nature09747.</cite> [<a href="https://doi.org/10.1038/nature09747" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21240260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Modelling%20the%20long%20QT%20syndrome%20with%20induced%20pluripotent%20stem%20cells&amp;author=I%20Itzhaki&amp;author=L%20Maizels&amp;author=I%20Huber&amp;author=L%20Zwi-Dantsis&amp;author=O%20Caspi&amp;volume=471&amp;publication_year=2011&amp;pages=225-229&amp;pmid=21240260&amp;doi=10.1038/nature09747&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib18">
<cite>Kannankeril P, Roden DM, Darbar D. Drug-induced long QT syndrome. Pharmacological Reviews. 2010;62:760–781. doi: 10.1124/pr.110.003723.</cite> [<a href="https://doi.org/10.1124/pr.110.003723" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2993258/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21079043/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacological%20Reviews&amp;title=Drug-induced%20long%20QT%20syndrome&amp;author=P%20Kannankeril&amp;author=DM%20Roden&amp;author=D%20Darbar&amp;volume=62&amp;publication_year=2010&amp;pages=760-781&amp;pmid=21079043&amp;doi=10.1124/pr.110.003723&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib19">
<cite>Kannankeril PJ, Roden DM, Norris KJ, Whalen SP, George AL, Murray KT. Genetic susceptibility to acquired long QT syndrome: pharmacologic challenge in first-degree relatives. Heart Rhythm. 2005;2:134–140. doi: 10.1016/j.hrthm.2004.10.039.</cite> [<a href="https://doi.org/10.1016/j.hrthm.2004.10.039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15851285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heart%20Rhythm&amp;title=Genetic%20susceptibility%20to%20acquired%20long%20QT%20syndrome:%20pharmacologic%20challenge%20in%20first-degree%20relatives&amp;author=PJ%20Kannankeril&amp;author=DM%20Roden&amp;author=KJ%20Norris&amp;author=SP%20Whalen&amp;author=AL%20George&amp;volume=2&amp;publication_year=2005&amp;pages=134-140&amp;pmid=15851285&amp;doi=10.1016/j.hrthm.2004.10.039&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib20">
<cite>Karakikes I, Senyei GD, Hansen J, Kong CW, Azeloglu EU, Stillitano F, Lieu DK, Wang J, Ren L, Hulot JS, Iyengar R, Li RA, Hajjar RJ. Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes. Stem Cells Translational Medicine. 2014;3:18–31. doi: 10.5966/sctm.2013-0110.</cite> [<a href="https://doi.org/10.5966/sctm.2013-0110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3902291/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24324277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stem%20Cells%20Translational%20Medicine&amp;title=Small%20molecule-mediated%20directed%20differentiation%20of%20human%20embryonic%20stem%20cells%20toward%20ventricular%20cardiomyocytes&amp;author=I%20Karakikes&amp;author=GD%20Senyei&amp;author=J%20Hansen&amp;author=CW%20Kong&amp;author=EU%20Azeloglu&amp;volume=3&amp;publication_year=2014&amp;pages=18-31&amp;pmid=24324277&amp;doi=10.5966/sctm.2013-0110&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib21">
<cite>Keller GA, Di Girolamo G. Prokinetic agents and QT prolongation: a familiar scene with new actors. Current Drug Safety. 2010;5:73–78. doi: 10.2174/157488610789869166.</cite> [<a href="https://doi.org/10.2174/157488610789869166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20210722/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Drug%20Safety&amp;title=Prokinetic%20agents%20and%20QT%20prolongation:%20a%20familiar%20scene%20with%20new%20actors&amp;author=GA%20Keller&amp;author=G%20Di%20Girolamo&amp;volume=5&amp;publication_year=2010&amp;pages=73-78&amp;pmid=20210722&amp;doi=10.2174/157488610789869166&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib22">
<cite>Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nature Methods. 2012;9:357–359. doi: 10.1038/nmeth.1923.</cite> [<a href="https://doi.org/10.1038/nmeth.1923" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3322381/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22388286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Methods&amp;title=Fast%20gapped-read%20alignment%20with%20Bowtie%202&amp;author=B%20Langmead&amp;author=SL%20Salzberg&amp;volume=9&amp;publication_year=2012&amp;pages=357-359&amp;pmid=22388286&amp;doi=10.1038/nmeth.1923&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib23">
<cite>Leonoudakis D, Conti LR, Anderson S, Radeke CM, McGuire LM, Adams ME, Froehner SC, Yates JR, Vandenberg CA. Protein trafficking and anchoring complexes revealed by proteomic analysis of inward rectifier potassium channel (Kir2.x)-associated proteins. Journal of Biological Chemistry. 2004;279:22331–22346. doi: 10.1074/jbc.M400285200.</cite> [<a href="https://doi.org/10.1074/jbc.M400285200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15024025/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biological%20Chemistry&amp;title=Protein%20trafficking%20and%20anchoring%20complexes%20revealed%20by%20proteomic%20analysis%20of%20inward%20rectifier%20potassium%20channel%20(Kir2.x)-associated%20proteins&amp;author=D%20Leonoudakis&amp;author=LR%20Conti&amp;author=S%20Anderson&amp;author=CM%20Radeke&amp;author=LM%20McGuire&amp;volume=279&amp;publication_year=2004&amp;pages=22331-22346&amp;pmid=15024025&amp;doi=10.1074/jbc.M400285200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib24">
<cite>Levy DI, Cepaitis E, Wanderling S, Toth PT, Archer SL, Goldstein SA. The membrane protein MiRP3 regulates Kv4.2 channels in a KChIP-dependent manner. The Journal of Physiology. 2010;588:2657–2668. doi: 10.1113/jphysiol.2010.191395.</cite> [<a href="https://doi.org/10.1113/jphysiol.2010.191395" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2916995/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20498229/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20Journal%20of%20Physiology&amp;title=The%20membrane%20protein%20MiRP3%20regulates%20Kv4.2%20channels%20in%20a%20KChIP-dependent%20manner&amp;author=DI%20Levy&amp;author=E%20Cepaitis&amp;author=S%20Wanderling&amp;author=PT%20Toth&amp;author=SL%20Archer&amp;volume=588&amp;publication_year=2010&amp;pages=2657-2668&amp;pmid=20498229&amp;doi=10.1113/jphysiol.2010.191395&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib25">
<cite>Liang P, Lan F, Lee AS, Gong T, Sanchez-Freire V, Wang Y, Diecke S, Sallam K, Knowles JW, Wang PJ, Nguyen PK, Bers DM, Robbins RC, Wu JC. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation. 2013;127:1677–1691. doi: 10.1161/CIRCULATIONAHA.113.001883.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.113.001883" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3870148/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23519760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Drug%20screening%20using%20a%20library%20of%20human%20induced%20pluripotent%20stem%20cell-derived%20cardiomyocytes%20reveals%20disease-specific%20patterns%20of%20cardiotoxicity&amp;author=P%20Liang&amp;author=F%20Lan&amp;author=AS%20Lee&amp;author=T%20Gong&amp;author=V%20Sanchez-Freire&amp;volume=127&amp;publication_year=2013&amp;pages=1677-1691&amp;pmid=23519760&amp;doi=10.1161/CIRCULATIONAHA.113.001883&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib26">
<cite>Liu Z, Liu X, Yu H, Pei J, Zhang Y, Gong J, Pu J. Common Variants in TRDN and CALM1 Are Associated with Risk of Sudden Cardiac Death in Chronic Heart Failure Patients in Chinese Han Population. PLOS One. 2015;10:e0132459.  doi: 10.1371/journal.pone.0132459.</cite> [<a href="https://doi.org/10.1371/journal.pone.0132459" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4510877/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26196381/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLOS%20One&amp;title=Common%20Variants%20in%20TRDN%20and%20CALM1%20Are%20Associated%20with%20Risk%20of%20Sudden%20Cardiac%20Death%20in%20Chronic%20Heart%20Failure%20Patients%20in%20Chinese%20Han%20Population&amp;author=Z%20Liu&amp;author=X%20Liu&amp;author=H%20Yu&amp;author=J%20Pei&amp;author=Y%20Zhang&amp;volume=10&amp;publication_year=2015&amp;pages=e0132459&amp;pmid=26196381&amp;doi=10.1371/journal.pone.0132459&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib27">
<cite>Lundy SD, Zhu WZ, Regnier M, Laflamme MA. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells and Development. 2013;22:1991–2002. doi: 10.1089/scd.2012.0490.</cite> [<a href="https://doi.org/10.1089/scd.2012.0490" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3699903/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23461462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stem%20Cells%20and%20Development&amp;title=Structural%20and%20functional%20maturation%20of%20cardiomyocytes%20derived%20from%20human%20pluripotent%20stem%20cells&amp;author=SD%20Lundy&amp;author=WZ%20Zhu&amp;author=M%20Regnier&amp;author=MA%20Laflamme&amp;volume=22&amp;publication_year=2013&amp;pages=1991-2002&amp;pmid=23461462&amp;doi=10.1089/scd.2012.0490&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib28">
<cite>Maguy A, Hebert TE, Nattel S. Involvement of lipid rafts and caveolae in cardiac ion channel function. Cardiovascular Research. 2006;69:798–807. doi: 10.1016/j.cardiores.2005.11.013.</cite> [<a href="https://doi.org/10.1016/j.cardiores.2005.11.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16405931/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular%20Research&amp;title=Involvement%20of%20lipid%20rafts%20and%20caveolae%20in%20cardiac%20ion%20channel%20function&amp;author=A%20Maguy&amp;author=TE%20Hebert&amp;author=S%20Nattel&amp;volume=69&amp;publication_year=2006&amp;pages=798-807&amp;pmid=16405931&amp;doi=10.1016/j.cardiores.2005.11.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib29">
<cite>Makkar RR. Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs. JAMA. 1993;270:2590–2597. doi: 10.1001/jama.1993.03510210076031.</cite> [<a href="https://doi.org/10.1001/jama.1993.03510210076031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8230644/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Female%20Gender%20as%20a%20Risk%20Factor%20for%20Torsades%20de%20Pointes%20Associated%20With%20Cardiovascular%20Drugs&amp;author=RR%20Makkar&amp;volume=270&amp;publication_year=1993&amp;pages=2590-2597&amp;pmid=8230644&amp;doi=10.1001/jama.1993.03510210076031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib30">
<cite>Mann DA. Human induced pluripotent stem cell-derived hepatocytes for toxicology testing. Expert Opinion on Drug Metabolism &amp; Toxicology. 2015;11:1–5. doi: 10.1517/17425255.2015.981523.</cite> [<a href="https://doi.org/10.1517/17425255.2015.981523" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25385341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opinion%20on%20Drug%20Metabolism%20&amp;%20Toxicology&amp;title=Human%20induced%20pluripotent%20stem%20cell-derived%20hepatocytes%20for%20toxicology%20testing&amp;author=DA%20Mann&amp;volume=11&amp;publication_year=2015&amp;pages=1-5&amp;pmid=25385341&amp;doi=10.1517/17425255.2015.981523&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib31">
<cite>McIntyre LM, Lopiano KK, Morse AM, Amin V, Oberg AL, Young LJ, Nuzhdin SV. RNA-seq: technical variability and sampling. BMC Genomics. 2011;12:293. doi: 10.1186/1471-2164-12-293.</cite> [<a href="https://doi.org/10.1186/1471-2164-12-293" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3141664/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21645359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Genomics&amp;title=RNA-seq:%20technical%20variability%20and%20sampling&amp;author=LM%20McIntyre&amp;author=KK%20Lopiano&amp;author=AM%20Morse&amp;author=V%20Amin&amp;author=AL%20Oberg&amp;volume=12&amp;publication_year=2011&amp;pages=293&amp;pmid=21645359&amp;doi=10.1186/1471-2164-12-293&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib32">
<cite>Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flügel L, Dorn T, Goedel A, Höhnke C, Hofmann F, Seyfarth M, Sinnecker D, Schömig A, Laugwitz KL. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. New England Journal of Medicine. 2010;363:1397–1409. doi: 10.1056/NEJMoa0908679.</cite> [<a href="https://doi.org/10.1056/NEJMoa0908679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20660394/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Patient-specific%20induced%20pluripotent%20stem-cell%20models%20for%20long-QT%20syndrome&amp;author=A%20Moretti&amp;author=M%20Bellin&amp;author=A%20Welling&amp;author=CB%20Jung&amp;author=JT%20Lam&amp;volume=363&amp;publication_year=2010&amp;pages=1397-1409&amp;pmid=20660394&amp;doi=10.1056/NEJMoa0908679&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib33">
<cite>Moss AJ, Robinson J. Clinical features of the idiopathic long QT syndrome. Circulation. 1992;85:I140–144.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1345816/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Clinical%20features%20of%20the%20idiopathic%20long%20QT%20syndrome&amp;author=AJ%20Moss&amp;author=J%20Robinson&amp;volume=85&amp;publication_year=1992&amp;pages=I140-144&amp;pmid=1345816&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib34">
<cite>Nabi IR. Cavin fever: regulating caveolae. Nature Cell Biology. 2009;11:789–791. doi: 10.1038/ncb0709-789.</cite> [<a href="https://doi.org/10.1038/ncb0709-789" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19568263/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Cell%20Biology&amp;title=Cavin%20fever:%20regulating%20caveolae&amp;author=IR%20Nabi&amp;volume=11&amp;publication_year=2009&amp;pages=789-791&amp;pmid=19568263&amp;doi=10.1038/ncb0709-789&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib35">
<cite>Navarrete EG, Liang P, Lan F, Sanchez-Freire V, Simmons C, Gong T, Sharma A, Burridge PW, Patlolla B, Lee AS, Wu H, Beygui RE, Wu SM, Robbins RC, Bers DM, Wu JC. Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays. Circulation. 2013;128:S3–S13. doi: 10.1161/CIRCULATIONAHA.112.000570.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.112.000570" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3855862/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24030418/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Screening%20drug-induced%20arrhythmia%20%5Bcorrected%5D%20using%20human%20induced%20pluripotent%20stem%20cell-derived%20cardiomyocytes%20and%20low-impedance%20microelectrode%20arrays&amp;author=EG%20Navarrete&amp;author=P%20Liang&amp;author=F%20Lan&amp;author=V%20Sanchez-Freire&amp;author=C%20Simmons&amp;volume=128&amp;publication_year=2013&amp;pages=S3-S13&amp;pmid=24030418&amp;doi=10.1161/CIRCULATIONAHA.112.000570&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib36">
<cite>Nozaki Y, Honda Y, Tsujimoto S, Watanabe H, Kunimatsu T, Funabashi H. Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation. Toxicology and Applied Pharmacology. 2014;278:72–77. doi: 10.1016/j.taap.2014.04.007.</cite> [<a href="https://doi.org/10.1016/j.taap.2014.04.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24742750/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxicology%20and%20Applied%20Pharmacology&amp;title=Availability%20of%20human%20induced%20pluripotent%20stem%20cell-derived%20cardiomyocytes%20in%20assessment%20of%20drug%20potential%20for%20QT%20prolongation&amp;author=Y%20Nozaki&amp;author=Y%20Honda&amp;author=S%20Tsujimoto&amp;author=H%20Watanabe&amp;author=T%20Kunimatsu&amp;volume=278&amp;publication_year=2014&amp;pages=72-77&amp;pmid=24742750&amp;doi=10.1016/j.taap.2014.04.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib37">
<cite>Odening KE, Koren G. How do sex hormones modify arrhythmogenesis in long QT syndrome? Sex hormone effects on arrhythmogenic substrate and triggered activity. Heart Rhythm. 2014;11:2107–2115. doi: 10.1016/j.hrthm.2014.06.023.</cite> [<a href="https://doi.org/10.1016/j.hrthm.2014.06.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4394187/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24954242/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heart%20Rhythm&amp;title=How%20do%20sex%20hormones%20modify%20arrhythmogenesis%20in%20long%20QT%20syndrome?%20Sex%20hormone%20effects%20on%20arrhythmogenic%20substrate%20and%20triggered%20activity&amp;author=KE%20Odening&amp;author=G%20Koren&amp;volume=11&amp;publication_year=2014&amp;pages=2107-2115&amp;pmid=24954242&amp;doi=10.1016/j.hrthm.2014.06.023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib38">
<cite>Paulussen AD, Gilissen RA, Armstrong M, Doevendans PA, Verhasselt P, Smeets HJ, Schulze-Bahr E, Haverkamp W, Breithardt G, Cohen N, Aerssens J. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. Journal of Molecular Medicine. 2004;82:182–188. doi: 10.1007/s00109-003-0522-z.</cite> [<a href="https://doi.org/10.1007/s00109-003-0522-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14760488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Molecular%20Medicine&amp;title=Genetic%20variations%20of%20KCNQ1,%20KCNH2,%20SCN5A,%20KCNE1,%20and%20KCNE2%20in%20drug-induced%20long%20QT%20syndrome%20patients&amp;author=AD%20Paulussen&amp;author=RA%20Gilissen&amp;author=M%20Armstrong&amp;author=PA%20Doevendans&amp;author=P%20Verhasselt&amp;volume=82&amp;publication_year=2004&amp;pages=182-188&amp;pmid=14760488&amp;doi=10.1007/s00109-003-0522-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib39">
<cite>Petropoulou E, Jamshidi Y, Behr ER. The genetics of pro-arrhythmic adverse drug reactions. British Journal of Clinical Pharmacology. 2014;77:618–625. doi: 10.1111/bcp.12208.</cite> [<a href="https://doi.org/10.1111/bcp.12208" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3971979/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23834499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Clinical%20Pharmacology&amp;title=The%20genetics%20of%20pro-arrhythmic%20adverse%20drug%20reactions&amp;author=E%20Petropoulou&amp;author=Y%20Jamshidi&amp;author=ER%20Behr&amp;volume=77&amp;publication_year=2014&amp;pages=618-625&amp;pmid=23834499&amp;doi=10.1111/bcp.12208&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib40">
<cite>Pfeufer A, Sanna S, Arking DE, Müller M, Gateva V, Fuchsberger C, Ehret GB, Orrú M, Pattaro C, Köttgen A, Perz S, Usala G, Barbalic M, Li M, Pütz B, Scuteri A, Prineas RJ, Sinner MF, Gieger C, Najjar SS, Kao WH, Mühleisen TW, Dei M, Happle C, Möhlenkamp S, Crisponi L, Erbel R, Jöckel KH, Naitza S, Steinbeck G, Marroni F, Hicks AA, Lakatta E, Müller-Myhsok B, Pramstaller PP, Wichmann HE, Schlessinger D, Boerwinkle E, Meitinger T, Uda M, Coresh J, Kääb S, Abecasis GR, Chakravarti A. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nature Genetics. 2009;41:407–414. doi: 10.1038/ng.362.</cite> [<a href="https://doi.org/10.1038/ng.362" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2976045/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19305409/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Genetics&amp;title=Common%20variants%20at%20ten%20loci%20modulate%20the%20QT%20interval%20duration%20in%20the%20QTSCD%20Study&amp;author=A%20Pfeufer&amp;author=S%20Sanna&amp;author=DE%20Arking&amp;author=M%20M%C3%BCller&amp;author=V%20Gateva&amp;volume=41&amp;publication_year=2009&amp;pages=407-414&amp;pmid=19305409&amp;doi=10.1038/ng.362&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib41">
<cite>Rajab A, Straub V, McCann LJ, Seelow D, Varon R, Barresi R, Schulze A, Lucke B, Lützkendorf S, Karbasiyan M, Bachmann S, Spuler S, Schuelke M. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS Genetics. 2010;6:e1000874.  doi: 10.1371/journal.pgen.1000874.</cite> [<a href="https://doi.org/10.1371/journal.pgen.1000874" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2837386/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20300641/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Genetics&amp;title=Fatal%20cardiac%20arrhythmia%20and%20long-QT%20syndrome%20in%20a%20new%20form%20of%20congenital%20generalized%20lipodystrophy%20with%20muscle%20rippling%20(CGL4)%20due%20to%20PTRF-CAVIN%20mutations&amp;author=A%20Rajab&amp;author=V%20Straub&amp;author=LJ%20McCann&amp;author=D%20Seelow&amp;author=R%20Varon&amp;volume=6&amp;publication_year=2010&amp;pages=e1000874&amp;pmid=20300641&amp;doi=10.1371/journal.pgen.1000874&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib42">
<cite>Roden DM. Long QT syndrome: reduced repolarization reserve and the genetic link. Journal of Internal Medicine. 2006;259:59–69. doi: 10.1111/j.1365-2796.2005.01589.x.</cite> [<a href="https://doi.org/10.1111/j.1365-2796.2005.01589.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16336514/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Internal%20Medicine&amp;title=Long%20QT%20syndrome:%20reduced%20repolarization%20reserve%20and%20the%20genetic%20link&amp;author=DM%20Roden&amp;volume=259&amp;publication_year=2006&amp;pages=59-69&amp;pmid=16336514&amp;doi=10.1111/j.1365-2796.2005.01589.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib43">
<cite>Roden DM. Cellular basis of drug-induced torsades de pointes. British Journal of Pharmacology. 2008a;154:1502–1507. doi: 10.1038/bjp.2008.238.</cite> [<a href="https://doi.org/10.1038/bjp.2008.238" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2492095/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18552874/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=Cellular%20basis%20of%20drug-induced%20torsades%20de%20pointes&amp;author=DM%20Roden&amp;volume=154&amp;publication_year=2008a&amp;pages=1502-1507&amp;pmid=18552874&amp;doi=10.1038/bjp.2008.238&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib44">
<cite>Roden DM. Repolarization reserve: a moving target. Circulation. 2008b;118:981–982. doi: 10.1161/CIRCULATIONAHA.108.798918.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.108.798918" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18765386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Repolarization%20reserve:%20a%20moving%20target&amp;author=DM%20Roden&amp;volume=118&amp;publication_year=2008b&amp;pages=981-982&amp;pmid=18765386&amp;doi=10.1161/CIRCULATIONAHA.108.798918&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib45">
<cite>Rolland T, Taşan M, Charloteaux B, Pevzner SJ, Zhong Q, Sahni N, Yi S, Lemmens I, Fontanillo C, Mosca R, Kamburov A, Ghiassian SD, Yang X, Ghamsari L, Balcha D, Begg BE, Braun P, Brehme M, Broly MP, Carvunis AR, Convery-Zupan D, Corominas R, Coulombe-Huntington J, Dann E, Dreze M, Dricot A, Fan C, Franzosa E, Gebreab F, Gutierrez BJ, Hardy MF, Jin M, Kang S, Kiros R, Lin GN, Luck K, MacWilliams A, Menche J, Murray RR, Palagi A, Poulin MM, Rambout X, Rasla J, Reichert P, Romero V, Ruyssinck E, Sahalie JM, Scholz A, Shah AA, Sharma A, Shen Y, Spirohn K, Tam S, Tejeda AO, Trigg SA, Twizere JC, Vega K, Walsh J, Cusick ME, Xia Y, Barabási AL, Iakoucheva LM, Aloy P, De Las Rivas J, Tavernier J, Calderwood MA, Hill DE, Hao T, Roth FP, Vidal M. A proteome-scale map of the human interactome network. Cell. 2014;159:1212–1226. doi: 10.1016/j.cell.2014.10.050.</cite> [<a href="https://doi.org/10.1016/j.cell.2014.10.050" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4266588/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25416956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=A%20proteome-scale%20map%20of%20the%20human%20interactome%20network&amp;author=T%20Rolland&amp;author=M%20Ta%C5%9Fan&amp;author=B%20Charloteaux&amp;author=SJ%20Pevzner&amp;author=Q%20Zhong&amp;volume=159&amp;publication_year=2014&amp;pages=1212-1226&amp;pmid=25416956&amp;doi=10.1016/j.cell.2014.10.050&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib46">
<cite>Sager PT, Gintant G, Turner JR, Pettit S, Stockbridge N. Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium. American Heart Journal. 2014;167:292–300. doi: 10.1016/j.ahj.2013.11.004.</cite> [<a href="https://doi.org/10.1016/j.ahj.2013.11.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24576511/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Heart%20Journal&amp;title=Rechanneling%20the%20cardiac%20proarrhythmia%20safety%20paradigm:%20a%20meeting%20report%20from%20the%20Cardiac%20Safety%20Research%20Consortium&amp;author=PT%20Sager&amp;author=G%20Gintant&amp;author=JR%20Turner&amp;author=S%20Pettit&amp;author=N%20Stockbridge&amp;volume=167&amp;publication_year=2014&amp;pages=292-300&amp;pmid=24576511&amp;doi=10.1016/j.ahj.2013.11.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib47">
<cite>Sarganas G, Garbe E, Klimpel A, Hering RC, Bronder E, Haverkamp W. Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany. Europace. 2014;16:101–108. doi: 10.1093/europace/eut214.</cite> [<a href="https://doi.org/10.1093/europace/eut214" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23833046/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Europace&amp;title=Epidemiology%20of%20symptomatic%20drug-induced%20long%20QT%20syndrome%20and%20Torsade%20de%20Pointes%20in%20Germany&amp;author=G%20Sarganas&amp;author=E%20Garbe&amp;author=A%20Klimpel&amp;author=RC%20Hering&amp;author=E%20Bronder&amp;volume=16&amp;publication_year=2014&amp;pages=101-108&amp;pmid=23833046&amp;doi=10.1093/europace/eut214&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib48">
<cite>Schaaf S, Shibamiya A, Mewe M, Eder A, Stöhr A, Hirt MN, Rau T, Zimmermann WH, Conradi L, Eschenhagen T, Hansen A. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One. 2011;6:e26397.  doi: 10.1371/journal.pone.0026397.</cite> [<a href="https://doi.org/10.1371/journal.pone.0026397" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3197640/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22028871/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Human%20engineered%20heart%20tissue%20as%20a%20versatile%20tool%20in%20basic%20research%20and%20preclinical%20toxicology&amp;author=S%20Schaaf&amp;author=A%20Shibamiya&amp;author=M%20Mewe&amp;author=A%20Eder&amp;author=A%20St%C3%B6hr&amp;volume=6&amp;publication_year=2011&amp;pages=e26397&amp;pmid=22028871&amp;doi=10.1371/journal.pone.0026397&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib49">
<cite>Sinnecker D, Goedel A, Dorn T, Dirschinger RJ, Moretti A, Laugwitz KL. Modeling long-QT syndromes with iPS cells. Journal of Cardiovascular Translational Research. 2013;6:31–36. doi: 10.1007/s12265-012-9416-1.</cite> [<a href="https://doi.org/10.1007/s12265-012-9416-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23076501/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cardiovascular%20Translational%20Research&amp;title=Modeling%20long-QT%20syndromes%20with%20iPS%20cells&amp;author=D%20Sinnecker&amp;author=A%20Goedel&amp;author=T%20Dorn&amp;author=RJ%20Dirschinger&amp;author=A%20Moretti&amp;volume=6&amp;publication_year=2013&amp;pages=31-36&amp;pmid=23076501&amp;doi=10.1007/s12265-012-9416-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib50">
<cite>Sinnecker D, Laugwitz KL, Moretti A. Induced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testing. Pharmacology &amp; Therapeutics. 2014;143:246–252. doi: 10.1016/j.pharmthera.2014.03.004.</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2014.03.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24657289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology%20&amp;%20Therapeutics&amp;title=Induced%20pluripotent%20stem%20cell-derived%20cardiomyocytes%20for%20drug%20development%20and%20toxicity%20testing&amp;author=D%20Sinnecker&amp;author=KL%20Laugwitz&amp;author=A%20Moretti&amp;volume=143&amp;publication_year=2014&amp;pages=246-252&amp;pmid=24657289&amp;doi=10.1016/j.pharmthera.2014.03.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib51">
<cite>Soyka LF, Wirtz C, Spangenberg RB. Clinical safety profile of sotalol in patients with arrhythmias. The American Journal of Cardiology. 1990;65:74A–81. doi: 10.1016/0002-9149(90)90207-H.</cite> [<a href="https://doi.org/10.1016/0002-9149(90)90207-H" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2403737/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20American%20Journal%20of%20Cardiology&amp;title=Clinical%20safety%20profile%20of%20sotalol%20in%20patients%20with%20arrhythmias&amp;author=LF%20Soyka&amp;author=C%20Wirtz&amp;author=RB%20Spangenberg&amp;volume=65&amp;publication_year=1990&amp;pages=74A-81&amp;pmid=2403737&amp;doi=10.1016/0002-9149(90)90207-H&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib52">
<cite>Terrenoire C, Wang K, Tung KW, Chung WK, Pass RH, Lu JT, Jean JC, Omari A, Sampson KJ, Kotton DN, Keller G, Kass RS. Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics. The Journal of General Physiology. 2013;141:61–72. doi: 10.1085/jgp.201210899.</cite> [<a href="https://doi.org/10.1085/jgp.201210899" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3536519/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23277474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20Journal%20of%20General%20Physiology&amp;title=Induced%20pluripotent%20stem%20cells%20used%20to%20reveal%20drug%20actions%20in%20a%20long%20QT%20syndrome%20family%20with%20complex%20genetics&amp;author=C%20Terrenoire&amp;author=K%20Wang&amp;author=KW%20Tung&amp;author=WK%20Chung&amp;author=RH%20Pass&amp;volume=141&amp;publication_year=2013&amp;pages=61-72&amp;pmid=23277474&amp;doi=10.1085/jgp.201210899&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib53">
<cite>Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009;25:1105–1111. doi: 10.1093/bioinformatics/btp120.</cite> [<a href="https://doi.org/10.1093/bioinformatics/btp120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2672628/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19289445/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=TopHat:%20discovering%20splice%20junctions%20with%20RNA-Seq&amp;author=C%20Trapnell&amp;author=L%20Pachter&amp;author=SL%20Salzberg&amp;volume=25&amp;publication_year=2009&amp;pages=1105-1111&amp;pmid=19289445&amp;doi=10.1093/bioinformatics/btp120&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib54">
<cite>Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nature Biotechnology. 2010;28:511–515. doi: 10.1038/nbt.1621.</cite> [<a href="https://doi.org/10.1038/nbt.1621" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3146043/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20436464/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Biotechnology&amp;title=Transcript%20assembly%20and%20quantification%20by%20RNA-Seq%20reveals%20unannotated%20transcripts%20and%20isoform%20switching%20during%20cell%20differentiation&amp;author=C%20Trapnell&amp;author=BA%20Williams&amp;author=G%20Pertea&amp;author=A%20Mortazavi&amp;author=G%20Kwan&amp;volume=28&amp;publication_year=2010&amp;pages=511-515&amp;pmid=20436464&amp;doi=10.1038/nbt.1621&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib55">
<cite>Turnbull IC, Karakikes I, Serrao GW, Backeris P, Lee JJ, Xie C, Senyei G, Gordon RE, Li RA, Akar FG, Hajjar RJ, Hulot JS, Costa KD. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. The FASEB Journal. 2014;28:644–654. doi: 10.1096/fj.13-228007.</cite> [<a href="https://doi.org/10.1096/fj.13-228007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3898643/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24174427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20FASEB%20Journal&amp;title=Advancing%20functional%20engineered%20cardiac%20tissues%20toward%20a%20preclinical%20model%20of%20human%20myocardium&amp;author=IC%20Turnbull&amp;author=I%20Karakikes&amp;author=GW%20Serrao&amp;author=P%20Backeris&amp;author=JJ%20Lee&amp;volume=28&amp;publication_year=2014&amp;pages=644-654&amp;pmid=24174427&amp;doi=10.1096/fj.13-228007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib56">
<cite>Wang Y, Liang P, Lan F, Wu H, Lisowski L, Gu M, Hu S, Kay MA, Urnov FD, Shinnawi R, Gold JD, Gepstein L, Wu JC. Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing. Journal of the American College of Cardiology. 2014;64:451–459. doi: 10.1016/j.jacc.2014.04.057.</cite> [<a href="https://doi.org/10.1016/j.jacc.2014.04.057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4149735/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25082577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20College%20of%20Cardiology&amp;title=Genome%20editing%20of%20isogenic%20human%20induced%20pluripotent%20stem%20cells%20recapitulates%20long%20QT%20phenotype%20for%20drug%20testing&amp;author=Y%20Wang&amp;author=P%20Liang&amp;author=F%20Lan&amp;author=H%20Wu&amp;author=L%20Lisowski&amp;volume=64&amp;publication_year=2014&amp;pages=451-459&amp;pmid=25082577&amp;doi=10.1016/j.jacc.2014.04.057&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib57">
<cite>Yang P, Kanki H, Drolet B, Yang T, Wei J, Viswanathan PC, Hohnloser SH, Shimizu W, Schwartz PJ, Stanton M, Murray KT, Norris K, George AL, Roden DM. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation. 2002;105:1943–1948. doi: 10.1161/01.CIR.0000014448.19052.4C.</cite> [<a href="https://doi.org/10.1161/01.CIR.0000014448.19052.4C" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11997281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Allelic%20variants%20in%20long-QT%20disease%20genes%20in%20patients%20with%20drug-associated%20torsades%20de%20pointes&amp;author=P%20Yang&amp;author=H%20Kanki&amp;author=B%20Drolet&amp;author=T%20Yang&amp;author=J%20Wei&amp;volume=105&amp;publication_year=2002&amp;pages=1943-1948&amp;pmid=11997281&amp;doi=10.1161/01.CIR.0000014448.19052.4C&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib58">
<cite>Zanetti LA. Sotalol: a new class III antiarrhythmic agent. Clinical Pharmacy. 1993;12:883–891.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/8137605/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Pharmacy&amp;title=Sotalol:%20a%20new%20class%20III%20antiarrhythmic%20agent&amp;author=LA%20Zanetti&amp;volume=12&amp;publication_year=1993&amp;pages=883-891&amp;pmid=8137605&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section></section><article class="sub-article" id="SA1"><section class="pmc-layout__citation font-secondary font-xs"><div>eLife. 2017 Jan 30;6:e19406. doi: <a href="https://doi.org/10.7554/eLife.19406.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.7554/eLife.19406.022</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision letter</h1></hgroup><div class="cg p">Editor: <span class="name western">Janet Rossant</span><sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.c" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a.c" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a.c" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.c" class="d-panel p" style="display: none"><div class="p" id="aff9">
<sup>1</sup>Hospital for Sick Children, Canada</div></div>
<div id="anp_a.c" class="d-panel p" style="display: none"><div class="notes p"><section id="historyfront-stub1" class="history"><p>Collection date 2017.</p></section></div></div>
<div id="clp_a.c" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<section class="bt xbox font-sm" id="boxed-text1"><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></section><p>Thank you for submitting your article "Modeling susceptibility to drug-induced long QT with a panel of subject-specific iPS cells" for consideration by <em>eLife</em>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Janet Rossant as the Senior Editor and Reviewing Editor. The reviewers have opted to remain anonymous.</p>
<p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p>
<p>Summary:</p>
<p>Stillitano and colleagues present an interesting translational study examining the ability of patient-specific iPS cells to report patient-specific responses to drug-induced long QT syndrome. This cardiotoxicity has led to multiple drug withdrawals as well as mandated safety testing for all new compounds seeking FDA approval. The authors have performed a clinical study in which they exposed volunteers to sotalol and measured changes in the electrocardiographic QT interval. They found that the patients exhibit a wide range of QTc responses. They then studied the extremes – high sensitivity and low sensitivity to sotalol. They generated patient specific iPS cell lines from the low and high sensitivity patients and differentiated them to cardiomyocytes, whose electrical properties were studied using a microelectrode array system. The authors found evidence that the adjusted field potential duration (aFDP), an in vitro surrogate for the QTc interval in the ECG segregated with the low and high sensitivity samples as assessed clinically. These findings support the hypothesis that iPSC-CMs can be used to report patient-specific responses to QT prolonging drugs. In addition, the authors did genomic analysis comparing high and low sensitivity samples finding some variability in SNPs. In addition, transcriptome analysis identified changes in expression levels of genes associated with cardiac repolarization comparing high and low sensitivity samples which is intriguing. The manuscript has several strengths. This is the first attempt to do such a prospective clinical trial rigorously testing iPSC-CM technology, and it addresses problem that is highly relevant for drug development, unanticipated drug-induced QT prolongation. The number of lines tested and characterized is substantial given the extent of analysis involved.</p>
<p>Essential revisions:</p>
<p>While the reviewers were impressed with the number of volunteers analyzed and the depth of the analysis, they had several concerns that raised questions about the validity of the results. Most importantly, they were concerned that the measurements of QT intervals were not undertaken using the most accurate and commonly accepted methodology, based on the example in <a href="#fig1" class="usa-link">Figure 1E</a>. For the high sensitivity example, the before measurement excluded the U wave and the after measurement includes the U wave thus extending the measured QT interval inappropriately in the post-sotalol measurement. Although there is not uniform consensus on QT interval measurement approaches, choosing the precordial wave with the largest T wave amplitude and variably including U waves is a potential problem that shakes confidence in the subsequent study that is absolutely dependent on the accuracy of these measurements. These measurements need to be substantiated.</p>
<p>Secondly, there was some concern that variability in cardiac differentiation efficiency among iPS lines could have influenced results. What measurements of iPSC-CM quality and purity were made routinely given that differentiation of different iPSC lines can yield different purity of CMs? This is a critical question since techniques taking whole preparations such as gene expression studies could be substantially impacted by contaminating cell types, e.g. 10% CMs from one line vs. 90% CMs from another line would not be expected to allow easy comparison of CM gene expression. This question is particularly raised because of the remarkable variability in various cardiac ion channel genes seen in <a href="#fig2s3" class="usa-link">Figure 2—figure supplement 3</a>, with some lines show 10-20 fold differences in expression.</p>
<p>Third, the authors have found no differential response in the cells to E4031 (pure hERG blocker). As the primary effect of sotalol is, as stated by the authors themselves, hERG inhibition, why did their correlation between QTc and drug effects not work for E4031 as well? This needs to be discussed.</p></section></article><article class="sub-article" id="SA2"><section class="pmc-layout__citation font-secondary font-xs"><div>eLife. 2017 Jan 30;6:e19406. doi: <a href="https://doi.org/10.7554/eLife.19406.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.7554/eLife.19406.023</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Author response</h1></hgroup><ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="anp_a.d" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a.d" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="anp_a.d" class="d-panel p" style="display: none"><div class="notes p"><section id="historyfront-stub2" class="history"><p>Collection date 2017.</p></section></div></div>
<div id="clp_a.d" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>Essential revisions:</p>
<p>While the reviewers were impressed with the number of volunteers analyzed and the depth of the analysis, they had several concerns that raised questions about the validity of the results. Most importantly, they were concerned that the measurements of QT intervals were not undertaken using the most accurate and commonly accepted methodology, based on the example in <a href="#fig1" class="usa-link">Figure 1E</a>. For the high sensitivity example, the before measurement excluded the U wave and the after measurement includes the U wave thus extending the measured QT interval inappropriately in the post-sotalol measurement. Although there is not uniform consensus on QT interval measurement approaches, choosing the precordial wave with the largest T wave amplitude and variably including U waves is a potential problem that shakes confidence in the subsequent study that is absolutely dependent on the accuracy of these measurements. These measurements need to be substantiated.</p>
<p>We fully agree with this comment and we apologize as <a href="#fig1" class="usa-link">Figure 1E</a> was indeed not submitted in its appropriate version. <a href="#fig1" class="usa-link">Figure 1E</a> which was initially provided was mistakenly taken from a working version of the figure. We apologize for this inattention. The revised <a href="#fig1" class="usa-link">Figure 1E</a> now shows typical ECG recordings in a high-sensitive and a low-sensitive subject. As detailed in the Methods section, we were indeed extremely careful in using highly accurate and standardized measurements of QT interval. A specific operating procedure was developed for ECG recordings, collections, transfer and analyses. The three consecutive complexes used for the measurements of the intervals were selected in periods with stable heart rate, stable baseline, absence of artifacts and U waves either absent or well differentiated from T-waves. Measurements were then performed using the tangent method by an investigator blindly of drug administration. Importantly, all ECG and measurements were reviewed by another cardiologist (still blinded of drug administration). As an extended example, we here provide the complete ECG recording and caliper positions (raw data, low resolution) for the high-s subject (baseline evaluation). All other ECG were recorded and measured in the same conditions (available on request).</p>
<p>The Methods section “ECG recording and analysis” has been updated accordingly.</p>
<figure class="fig xbox font-sm" id="fig6"><h2 class="obj_head">Author response image 1.</h2>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed13/5279943/045bd2202091/elife-19406-resp-fig1.jpg" loading="lazy" height="166" width="718" alt="Author response image 1."></p>
<div class="p text-right font-secondary"><a href="figure/fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.021</a></p></figcaption></figure><p>Secondly, there was some concern that variability in cardiac differentiation efficiency among iPS lines could have influenced results. What measurements of iPSC-CM quality and purity were made routinely given that differentiation of different iPSC lines can yield different purity of CMs? This is a critical question since techniques taking whole preparations such as gene expression studies could be substantially impacted by contaminating cell types, e.g. 10% CMs from one line vs. 90% CMs from another line would not be expected to allow easy comparison of CM gene expression. This question is particularly raised because of the remarkable variability in various cardiac ion channel genes seen in <a href="#fig2s3" class="usa-link">Figure 2—figure supplement 3</a>, with some lines show 10-20 fold differences in expression.</p>
<p>We agree that inter-line variability in the efficiency of differentiation has been reported. Therefore, we systematically performed cardiac troponin T (cTNT<sup>+</sup>) Flow Cytometry in all iPSC-CM lines at day 25 of differentiation. We found an average of 47.8±19.9% cTNT+ cells. Importantly, after unblinding, we did not observe any differences between iPSC lines from the high-S vs. low-S groups (49.2±24.4% vs. 46.7±17.3% respectively, p=0.42). This has been added to the Results section (subsection “Derivation and differentiation of iPSCs into cardiomyocytes”, last paragraph).</p>
<p>For measurements of iPSC-CMs quality, each line was tested for the presence of key CMs identity markers (sarcomeric proteins troponin T (cTnT), α-actinin and for the gap-junction protein connexin 43 (Cx43)) by immunostaining. A representative image is reported in <a href="#fig2" class="usa-link">Figure 2A</a>. The MEA recordings were performed on a layer of iPSC-CMs that had spontaneous beating activity and had measurable field potential duration (FPD) as they developed contact with the electrodes. It seems unlikely that contaminating cell types would have influenced these results. In addition, patch clamp experiments were performed at the cell level on two different couples of iPSC-CM lines from each group (low-S and high-S) and confirmed the MEA results (see previous and new <a href="#fig4" class="usa-link">Figure 4</a>). Finally, our gene expression studies were indeed performed on whole preparations because of challenges in enriching preparations in derived cardiomyocytes. For our transcriptomic study, we thus decided to use a prior knowledge based approach (on cardiac repolarization / LQTS neighborhood; based on a previously published methodology) to identify signals that are specifically coming from cardiomyocytes in these preparations. Indeed, a direct neighbor of a LQTS gene is anticipated to be cardiomyocyte specific. The expression of cardiac ion channel genes indeed appears variable (<a href="#fig2s3" class="usa-link">Figure 2—figure supplement 3</a>) but was similar between both groups (Low-S and high-S), as also further confirmed in our transcriptomic analysis (<a href="#fig5" class="usa-link">Figure 5A</a> and Results section, subsection “Dysregulation of downstream regulators of cardiac ion channels”). For all of these reasons, we think we have limited the influence of variability in cardiac differentiation efficiency among iPS lines on our results. Our multiple investigations did not indicate a systematic bias favoring one group as compared to the other.</p>
<p>Third, the authors have found no differential response in the cells to E4031 (pure hERG blocker). As the primary effect of sotalol is, as stated by the authors themselves, hERG inhibition, why did their correlation between QTc and drug effects not work for E4031 as well? This needs to be discussed.</p>
<p>We thank the reviewers and editors for this comment. As pointed out, E-4031 is an experimental drug that is a selective hERG channel blocker whereas sotalol is a clinically used drug that is a non-selective competitive β-adrenergic receptor blocker with additional Class III antiarrhythmic properties by its inhibition of potassium channels. We found that trends in response to E-4031 (both for EC50 and maximal effect) were in the same direction than with sotalol but these trends did not reach statistical significance. The two compounds differ in their pharmacological characteristics in terms of inhibition potency and target selectivity. First, as compared to sotalol, E-4031 is a more potent hERG blocker with an IC<sub>50</sub> value reported to be in the range of 10-100nM (vs. 10-50 µM for sotalol) and presents a very steep concentration-response effect (as observed in our lines, Figure 2—figure supplement 4C). It is thus possible that subtle differences in the susceptibility to develop prolonged cardiac repolarization in response to a given drug cannot be fully revealed when using a very potent inhibitor such as E-4031. Second, sotalol is thought to primarily prolong cardiac repolarization through hERG inhibition but sotalol can also affect other cardiac repolarization components. Our own transcriptomic results indicate that higher susceptibility to diLQT was associated with significant changes in expression of genes related to the regulation of ion channels homeostasis while the expression of cardiac ion channels (including hERG) was similar between both groups. A direct or indirect effect of sotalol on these components (in addition to its hERG effect) could explain the apparently discrepant results obtained with E-4031. This hypothesis would however deserve further investigations. The discussion has been corrected accordingly.</p></section></article><article class="sub-article" id="_ad93_"><section class="pmc-layout__citation font-secondary font-xs"><div></div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Associated Data</h1></hgroup><ul class="d-buttons inline-list"></ul>
<div class="d-panels font-secondary-light"></div>
<div></div>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
</div></section><section class="body sub-article-body"><section id="_adsm93_" lang="en" class="supplementary-materials"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>Figure 2—source data 1. iPSCs characterization.</span><p>Representative immunostaining for a panel of pluripotent stem cell markers, including Nanog, OCT4, SSEA4 and TRA1-60. Results are reported for each cell line. Typical staining in hESC is reported as a positive control. Scale bar 50 μM.</p>
<p><strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.008</a></p>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/5279943/bin/elife-19406-fig2-data1.pdf" data-ga-action="click_feat_suppl" class="usa-link">elife-19406-fig2-data1.pdf</a><sup> (44.9MB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7554/eLife.19406.008</div>
</div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>Figure 2—source data 2. Expression of main human cardiac ion channels.</span><p>Quantitative PCR results for the expression of 10 major cardiac ion channels including <em>SCN5A, CACNA1, KCNQ1, KCNE1, KCNJ2, KCNJ11, KChIP2, HCN1, HCN2, HCN4. KCND3</em> was not detected. Adult LV tissue is used as a positive control and the level of expression in human embryonic stem cells-derived cardiomyocytes as a comparator.</p>
<p><strong>DOI:</strong>
<a href="https://doi.org/10.7554/eLife.19406.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://dx.doi.org/10.7554/eLife.19406.009</a></p>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/5279943/bin/elife-19406-fig2-data2.pdf" data-ga-action="click_feat_suppl" class="usa-link">elife-19406-fig2-data2.pdf</a><sup> (6.5MB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.7554/eLife.19406.009</div>
</div></section></section></section></article><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from eLife are provided here courtesy of <strong>eLife Sciences Publications, Ltd</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.7554/eLife.19406"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/elife-19406.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/5279943/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/5279943/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC5279943%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC5279943/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC5279943/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC5279943/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/28134617/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC5279943/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/28134617/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC5279943/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/5279943/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="Uj1IXVIrwvuTUQGXmaMKi4tQcIahPePFPuzxbbR3BSqHlFZSbfX5cMMjMefIonsh">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
